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Abstract
Human retina is a diverse and important tissue, vastly studied for various retinal and other diseases.
Diabetic retinopathy (DR), a leading cause of blindness, is one of them. This work proposes a novel
and complete framework for the accurate and robust extraction and analysis of a series of retinal
vascular geometric features. It focuses on studying the registered bifurcations in successive years of
progression from diabetes (no DR) to DR, in order to identify the vascular alterations. Retinal fundus
images are utilised, and multiple experimental designs are employed. The framework includes various
steps, such as image registration and segmentation, extraction of features, statistical analysis and
classification models. Linear mixed models are utilised for making the statistical inferences, alongside
the elastic-net logistic regression, boruta algorithm, and regularised random forests for the feature
selection and classification phases, in order to evaluate the discriminative potential of the investigated
features and also build classification models. A number of geometric features, such as the central
retinal artery and vein equivalents, are found to differ significantly across the experiments and also
have good discriminative potential. The classification systems yield promising results with the area
under the curve values ranging from 0.821 to 0.968, across the four different investigated combinations.
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1. Introduction
Retinal image analysis remains a challenging and versatile field of study. A number of retinal
[1, 2, 3], cardiovascular [4] and systemic diseases [5] can be identified by studying the retinal vasculature
and the morphological changes. Although retinal vascular alterations are subtle, early recognition of
the signs can be paramount for helping prevent ophthalmologic complications and vision loss. The
∗Corresponding author. Tel.:+44(0)7951053731
Email address: gleontidis@lincoln.ac.uk (Georgios Leontidis)
Preprint submitted to Elsevier October 4, 2017
earlier the disease is identified the more efficient the treatment plan can be [6]. In addition to the effort
that is placed on providing accurate vessel segmentation and estimating geometric features, which itself
entails many challenges, the structure and the dynamic character of the retina is another problem that
concerns the present study - especially when it comes to the early detection of the progression from
diabetes-NoDR to diabetic retinopathy (DR).
1.1 Background
The human retina is an important, non-invasive window for monitoring the blood vessels [7]. DR
is a vision-threatening disease that affects the retinal blood vessels and is primarily a consequence of
diabetes [6]. It is characterised by lesions and vascular abnormalities, which include microaneurysms,
haemorrhages, cotton wool spots, exudates (bright spots), venous beading, intra-retinal microvascular
abnormalities, neovascularisation, loop and fibrous proliferation [8].
To stress how big of a problem diabetes and DR are, from an epidemiological perspective, it is
worth quoting the official numbers of the World Health Organization (WHO), which suggests that
between 1980 and 2014 the number of people with diabetes has risen from 108 million to a massive
422 million. 2.6 % of global blindness can be attributed to diabetes [6].
The above definition of the problem is enough to appreciate the importance of identifying the
signs of the proliferation of diabetes early, at a stage where no lesions exist yet (no DR), but only mild
vascular geometric alterations (pre-DR/diabetes-NoDR stage). To do so successfully, three main things
need to be achieved. First, the design of comprehensive experiments that focus on the progression of
the disease (effects of diabetes to the retina, culminating in first diagnosis of DR), by studying the
exact same subjects over a period of time [9]. Second, many different features, and a combination
of them, need to be evaluated, not only statistically but also for their discriminative potential. And
third, a unified framework is needed that will standardise the process, by combining image processing
and machine learning techniques. This will offer a way of studying the progression in successive years
within the same cohort, and also accommodate large scale studies in DR and/or other retinal diseases,
such as sickle cell retinopathy and retinopathy of prematurity.
1.2 Related Work and Motivation
Numerous studies exist in literature that have presented novelties and advances in retinal image
segmentation and registration techniques, as well as in the extraction and estimation of geometric fea-
tures [10, 11, 12, 13]. All these methods have justified their importance, by stressing their contribution
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in studying different retinal diseases, albeit not always happening in practice, as they are not usually
made publicly available - or have been developed in a purely research manner.
Regarding the studies about retinal diseases, there are many that have focused on finding associa-
tions between vascular changes and retinal diseases, investigating features, such as vessels widths and
angles [14, 2], fractal dimension (FD) [15], tortuosity [16], arteriovenous ratio (AVR) [17], haemody-
namic features [18, 19], etc. However, no previous studies exist - to the extent the present work does -
that investigate at the same time and in multiple experimental designs (for validation and comparison
purposes) many candidate features, by not only using proper statistical methods but also building mul-
tiple classification models. The former aims to provide information about how each feature changes
across the investigated periods of time and the latter about the discriminative potential of them, when
utilised for detecting the pre/post- DR stages.
In comparison to other very recent studies that have focused on detecting DR early, the proposed
approach is entirely different. For instance, the studies in [20, 21, 22] are utilising lesions, such as
microaneurysms and haemorrhages, as features to detect DR. In addition, the aim of the present work
supplements the purpose of them, in such a way that we are adding to the existing body of knowledge
information about what happens to the retinal vasculature a few years before DR, culminating the
diagnosis of DR (onset). As a matter of fact in [21], the No-DR group includes subjects that either
have diabetes-NoDR or mild-DR (scale 0 or 1 of the international clinical diabetic retinopathy disease
severity scale [23]). In the present study, the mild-DR stage (actually the first year that DR was
diagnosed by the DR graders of the hospital) is our terminal group. No other study, to the best of our
knowledge, deals with the challenging task of identifying vascular geometric changes well before the
onset of DR. In addition, no attempt to automate the DR grading is intended, since this study neither
focuses on lesions, nor it targets the same stages of DR, as the studies in [20, 21, 22] do.
Finally, no framework has ever been proposed whatsoever that aims to standardise and facilitate
the analyses and classification systems that follow, combining image processing, statistics and machine
learning techniques. To accommodate the aims and objectives of this work, the database that is de-
scribed in the next section and in the supplementary materials was created, by extracting retrospective
data.
1.3 Purpose of the Proposed Framework and Studies
The purpose of this work is a) to introduce a novel machine-learning based framework and method-
ology based on established image processing and machine learning techniques, in order to study the
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retinal vascular changes, b) to present statistical analyses tailored to the specific requirements of each
experimental design, and c) to demonstrate a comprehensive evaluation of the discriminative potential
of the investigated features. The pipeline of the proposed framework is comprised of the following
steps, which are going to be described in the next section:
1. Image registration
2. Vessel segmentation and junction measurements
3. Automated matching of bifurcations
4. Extraction of investigated features
5. Statistical analysis and inferences
6. Feature selection and classification
Mathworks Matlab software [24] was utilised for all the algorithms that were used or developed for
steps 1-4. Regarding steps 5 and 6, the open source language R and Rstudio [25] were used. The scope
of the framework is to accommodate the proposed way of analysis, as introduced in [2, 17], where the
same exact segments are studied over a period of time, retrospectively. A total number of forty five
geometric features, and derivatives of them, were measured or estimated using the framework, followed
by the analysis, feature selection and classification processes.
1.4 Novelty and Contribution
This work presents a number of novelties, including ideas that are introduced for the first time
in literature. First, no framework exists that proposes specific steps for the investigation of retinal
diseases and the implementation of classification systems. This novel framework, henceforth termed
framework for retinal imaging and feature analysis for retinal diseases (FRiAReD), establishes the
basis and offers a pipeline that is able not only to automate the process and speed up the analysis
of retinal images and the extraction of multiple features, but also ascertain that the bifurcations are
correctly registered across the multiple images of the same subject (progression study), and the analysis
is valid and therefore meaningful. Second, no other study exists that includes all these features at once
and compares many different experimental designs with each other, for exploiting the advantages of
matching and studying the same junctions and subjects across a period of time.
The main contributions of this work in the body of literature are summarised in brief as follows:
1. The first major contribution is the proposed framework and experimental design (study 1) that
offer an efficient and accurate way to robustly study the alterations in the retinal vasculature,
4
for identifying and detecting the progression from diabetes-NoDR to DR early. This can have an
important clinical implication, because the proliferation of the disease can sometimes be rapid,
leading to irreversible damages in the retinal tissue. Coming up with a framework of automated
analysis and detection could help clinicians monitor the effects that diabetes has in the retinal
vascular geometry more closely and/or adjust the treatment plans of the patients. FRiAReD is
a step closer to accomplishing this.
2. The second contribution is that a number of investigated features are evaluated at the same time,
and a series of classification models are built that only include geometric features, for testing the
potential of deploying into clinical practice such detection systems, which can have important
implications. All these solely by including geometric features, without extracting information
regarding the lesions.
The rest of the article is organised as follows. Section 2 introduces the methods and studies, followed
by section 3 that presents the results and a discussion of the findings. Section 4 is devoted to the
conclusion of this article and future work. Section 5 refers to the supplementary materials, which
contain important information about the numerical results of the statistical analysis.
2. Methods and Materials
2.1 Data Collection and Studies Overview
All of the studies were performed according to the tenets of the Declaration of Helsinki. In order to
investigate and study the progression of the disease over a few year period, and minimise errors coming
from factors that cannot be dealt with in advance, such as age, gender, lifestyle and the diversity of
different retinas, a retrospective study was planned, as initially described in [2]. To accomplish that,
data coming from subjects that progressed from diabetes-NoDR to DR were collected, in order to study
the exact same segments over a period of time, and identify vascular changes that one can be confident
enough that they can be attributed to the effects that diabetes has to the retinal vasculature. All the
images were obtained from the diabetic eye screening service of the Pilgrim hospital in Boston in the
UK. The images are graded (R0: Subject with diabetes but no DR, R1: Subject with diabetes with
background mild-DR, i.e. only microaneurysms)) by the DR graders of the hospital that the screening
takes place, according to the standards and protocols defined by the UK NHS [26]. Images from a
total number of 127 subjects were extracted, covering a period of four consecutive years (progressors
group - 3 years pre-DR plus the onset of DR). The quality of images is good enough with minimal to
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Figure 1: Two good quality and gradeable retinal images can be seen. In both images, all the areas of interest inside
the retina can be seen clearly, without artefacts or blurriness.
no artefacts, so that all vessels appear clearly (Figure 1). For all subjects fundus images of both eyes
are available. The eye in which DR first appeared was chosen. In the cases where this happened at
the same year, one of the two eyes was randomly selected.
In addition, a control group of 27 subjects with diabetes was also extracted that had not progressed
to DR at the time of the data collection (non-progressors group). For that group also the last four
consecutive years of the disease were selected. This group is needed in order to make some additional
analyses, beyond the progression study, for comparison purposes (non-progressors). All subjects in
both groups had no other known retinal or cardiovascular disease.
Both the temporal (macula centred) and nasal (optic disc centred) images were extracted, with the
latter category to be used for estimating the arteriovenous ratio (AVR) and the central retinal vein
and artery equivalents (CRVE and CRAE), and the former for all the other studies. The resolution
of these images was 1700X1700 with a field of view 45◦. Moreover, the average group age for both
the non-progressors and progressors groups were very close (mean age 54.5 (±7.8) and 53.4 (±8.4) for
progressors and non-progressors, respectively). The extracted data only include images from subjects
for whom four consecutive years of progression were available (out of the more than one thousand
subjects that were reviewed in the initial database in order to find those with the appropriate history
and the availability of all the necessary data).
Table 1 includes information about the planned studies, as will be used for the statistical analysis
of all the investigated features across the different stages of both diabetes and DR. The exact data
extraction information can be found in the supplementary materials.
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Table 1: Summary of the Planned Experiments
Studies Experimental Design Description Particulars
Study 1 Progressors group - four
year period of progression
with registered segments
(four groups - main study)
• Four years of progression,
starting from the three
consecutive years pre-DR
until the onset of DR, i.e.
three years pre-DR, two
years pre-DR, one year pre-
DR and onset of DR
• Exact same segments and
subjects are included in all
four years
Truly identify and asso-
ciate any vascular changes
with the progression of
the disease, given that the
same exact segments are
investigated
Study 2 Progressors group - four
year period of progression
with non-registered seg-
ments (four groups)
• Similar to study 1, but
the bifurcations are not
registered, so no measure-
ments are discarded
• Imbalanced groups (non-
registered bifurcations; bi-
furcations might be the
same or different across
groups)
Direct comparison with
study 1 to investigate
whether matching the
bifurcations affects the
results. This is the stan-
dard process of analysis in
literature
Study 3 Non-Progressors group -
four year period of progres-
sion with registered seg-
ments without DR (four
groups)
• Same subjects and seg-
ments across a four year
period, which does not in-
clude DR
• Subjects with diabetes
who have not progressed to
DR
Evaluate to what extent di-
abetes affects the retinal
vasculature in a four year
period, and compare with
the progression to DR, as
outlined in Study 1
Study 4 Non-Progressors group -
four year period of progres-
sion with non-registered
segments without DR (four
groups)
• Similar to study 3, but
the bifurcations are not
registered, so no measure-
ments are discarded
• Imbalanced groups (non-
registered bifurcations;
across groups bifurcations
might be the same or
different)
Direct comparison with
study 3 to investigate
whether matching the
bifurcations affects the
analysis and the results
Study 5 Averaged non-progressors
group (one group) versus
averaged progressors group
(one group) versus DR-
only group (one group)
• Does not include the
same subjects; the three
independent groups of the
disease’s stage (milestones
of progression) are com-
pared
The purpose is indeed
to find out, whether
any significant vascular
changes occur, during
the transition from the
non-progressed stage to
the progressed, and finally
to DR
Study 6 Progressors group - four
year period of progression
with independent groups
(different individuals in
each group)
• Similar to study 2, this
study intends to investi-
gate whether there is any
notable reason to prefer the
more demanding and sensi-
tive analysis of study 1
• Different subjects and
segments across 1‘groups
The stages of the disease
are similar to study 1, but
the subjects are indepen-
dent and non-registered
across the four year pe-
riod. Direct comparisons
with the results of study
1 will be made, given that
the data reflect the same
period of progression, but
within independent groups
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Figure 2: Workflow of the proposed framework
2.2 FRiAReD
An overview of the steps and processes that FRiARed includes, are illustrated in Figure 2. A
detailed description of each step and process is given in this section.
2.2.1 Image Registration
When studying the progression of a disease, it is paramount to be able to compare the same
segments over a period of time, mainly for two reasons. First, for eliminating, as far as possible, the
errors due to other conditions that affect the measurements, e.g. age, gender, lifestyle, etc., and second
for being confident enough that any measured differences can be attributed to the effects of the disease.
Doing the opposite, i.e. comparing independent groups and non-registered measurements, requires a
much larger sample, because one can inconsistently include and measure large and small vessels across
the whole cohort. An efficient and practical way to resolve these issues is to register the bifurcations
that come from the same subjects, in order to automatically identify and include only the registered
ones, across the images of the same subject.
For the purpose of FRiAReD, the open source library VLFeat [27] was used, implemented in
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Matlab, created by Vedaldi and Fulkerson, which offers a complete registration algorithm, based on the
scale-invariant features transform (SIFT) and homography estimation with random sample consensus
(Ransac). Following the above processes, the images are registered prior to segmenting the vessels,
in order the bifurcations to be aligned, and automatically match them, based on their individual
coordinates.
In brief, SIFT combines together a feature detector and a feature descriptor [28]. The detector
extracts from the image a number of attributed regions in a way that is consistent with some variations
of the illumination, the viewpoint and other viewing conditions. The descriptor associates to those
regions a signature, which identifies their appearance in a compact and robust way. Then a regular
Euclidean distance is used, i.e. the distance between descriptor i from image A and descriptor j from
image B [27]. For each descriptor in image A, the algorithm calculates the distance to all the descriptors
in image B, matching it with the closest one from B; otherwise the descriptor in A is not matched at
all. In order for SIFT to achieve rotation invariance and a high level of efficiency key locations are
chosen at maxima and minima of a difference of Gaussian function applied in scale space. A way to
efficiently achieve that is to build an image pyramid with resampling between each level [28].
Image gradients and orientations are extracted by processing the smoothed image at each level
of the pyramid. At each pixel, Ai,j , the image gradient magnitude, Mi,j , and orientation, Oi,j , are
computed using image differences (equations 1 and 2).
Mij =
√
(Aij −Ai+1,j)2 + (Aij −Ai,j+1)2 (1)
Oij = atan2(Aij −Ai+1,j , Ai,j+1 −Aij) (2)
Following that, a homography is estimated that describes the transformation between the two
images (equation 3) [29].

x2
y2
z2
 =

H11 H12 H13
H21 H22 H23
H31 H32 H33


x1
y1
z1
⇔ x2 = Hx1 (3)
Since the homography is defined up to scale, it has 8 degrees of freedom, hence requiring four point
correspondences to estimate [30]. At this point, since not all correspondences are correct, Ransac
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is used to find a set of good matches (inliers). This is achieved by randomly choosing 4 matches,
estimating the homography by using these matched pairs, and counting how many other matches
agree. A match between the point of image A = (Xa,Ya) and the point of image B = (Xb,Yb) agrees
with the transformation, if the transformed point H(A)=(X’a, Y’b) is close to point B [31].
The flowchart of the processes involved can be seen in Figure 3.
Figure 3: Flowchart of the image registration process.
Figure 4 shows an example of four registered images from our dataset, both separately and fused
together.
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Figure 4: Four registered images and a fused one. a: Reference image. b,c,d: Subsequent registered images. e: Fused
image. The bifurcations are adequately aligned, in order to be reliably registered.
2.2.2 Vessel Segmentation and Junction Measurements
Following the image registration, the vessels of the registered images are then segmented, using a
segmentation algorithm, whose accuracy, reliability and robustness has been evaluated in literature
[32]. This algorithm works by growing a ”Ribbon of Twins” active contour model, which uses two
pairs of contours to capture each vessel’s edge, while maintaining width consistency. At first, the
algorithm is initialised using a generalised morphological order filter to identify approximate vessels’
centrelines. The output of the filter is defined as follows. Let T be a binary filter mask of size M x
M, with #T the number of nonzero elements, and let R be an M x M region of the image, centred
at a given pixel. Let S(i, R, T) be the ith largest element of R masked by T. Let TIj and T
O
j be
the j th inner and outer tramline filters respectively. Consequently, the filter output is then defined as
∧j(S(#TOj - 2, R, TOj ) - S(3, R, TIj ) < θ), where θ = 0, is the filtering method. The Ribbon of twins
(ROT) is an active contour based model for segmenting retinal vessels. Each ROT has four linked
active contours, vc(s, t) = (xc(s, t), yc(s, t)), c ∈ {−2,−1, 1, 2}, where x and y are coordinate functions
of the parameter s ∈ [0, 1], and t is time. After identifying the vessel segments, the network topology
is determined using an implicit neural function, in order to resolve junction configurations. It also
yields precise vessel width measurements, with sub-pixel average width errors. Detailed information
and further justification can be found in [32]. Figure 5 shows the flowchart of the steps involved in the
segmentation process.
Figure 6 shows an example of the segmentation of two images used in this study. It is worth pointing
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Figure 5: Flowchart of the vessel segmentation process.
Figure 6: Two images with the vessels segmented can be seen, using the algorithm proposed in [32].
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out that all of the specific techniques that are adopted in this study to implement the FRiAReD (SIFT
for image registration, active contours for vessel segmentation, etc.) could be replaced with alternative
ones, as long as they can accommodate the requirements and the purpose of this framework.
2.2.3 Automated Registering of the Bifurcations
Just like OD and fovea, bifurcations are also anatomical landmarks inside the retina. The position
of each bifurcation is more or less fixed, with only negligible changes occurring. Given that the vast
majority of the investigated features are extracted in reference to the bifurcations, then a way to make
sure that the system will select and compare the same segments during the investigated period of time
is by registering the bifurcations. In this way, we make sure that the exact same vessel segments are
compared, minimising the chances of making false comparisons. Therefore, although the bifurcations
themselves, or more precisely the bifurcation points, do not have any particular importance as features,
their almost fixed spatial location, alongside the vessels that form a bifurcation, are highly important
and indispensable part of this study. An example of two bifurcations can be seen in Figure 7, which
are the same ones, but from two different time periods. Although the registration of the bifurcations
is automated, the labelling of arteries and veins is done in semi-automated manner.
Figure 7: Two bifurcations, belonging to the same subject, but captured in two different time periods of the disease.
Regarding the final iterative process for matching all the segments across the four year period, this
is based on multiple conditions, outlined as follows.
1. First, a segment is labelled as artery or vein with a tool presented in [33]. All the labellings were
fulfilled by two raters, ending up with a 97,5% kappa inter-rater agreement, thus keeping only
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the mutually agreed segments and discarding the rest.
2. Second, the images that come from the same subject are automatically identified, by searching
and matching their unique identification numbers, in order to make sure that all four images are
available.
3. Following that, only a vein or artery (V or A in our data) is selected at a time; the search is
restricted to the respective type of segment, until all of them have been identified.
4. The process starts with the coordinates of a single bifurcation point of an artery and continues
with the selection of the first pair of coordinates of the first image of the first subject. The
search is only conducted in a 10X10 pixel window about the same coordinates of the other three
images of the same subject, which is adequate in order not to miss a not perfectly registered
bifurcation - but at the same time not mistakenly include a wrong nearby one. In case more
than one bifurcations are found, the algorithm will prompt the user to choose one of them. If
both x and y coordinates are within the margins of the defined window in all four images, then
the feature name, the period of time, and measurements that correspond to the four registered
bifurcations are stored.
5. Finally, the identified matched entries are replaced with zero values and the previous steps
are repeated. After the process is finished, the remaining non-zero values are returned, which
correspond to the non-registered bifurcations, for possible further investigations. The same
process is repeated for the veins.
To make sure that all bifurcations have been registered correctly and the analysis conducted in a
proper way, all the registered bifurcations in the corresponding studies were also manually inspected
to affirm the suitability of this approach. Given the very good quality of the images and the efficient
image registration technique, all the registered bifurcations that were returned after the above process
(across the four year period) were identified correctly.
2.2.4 Extraction of the investigated features
As already pointed out, there are numerous studies in literature, having investigated the importance
of the retinal geometry in studying different pathologies. However some of the underlying biological
processes that might trigger these alterations, are still not well-known [34, 35, 36]. This section provides
more information regarding the investigated features and the tools that were used to extract them,
prior to describing the experiments and the findings. A cumulative list of all the investigated features,
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Table 2: Investigated features as used in the statistical analysis
Features (Short form)
1. Alpha value of arteries (AlphaA) 24.Venular Angle-to-Branching coefficient
2. Branching coefficient of arteries (BetaA) ratio(Angle.BC V)
3. Bifurcation index of arteries (LambdaA) 25.Fractal dimension(Fractal)
4. Diameter ratio λ1 of arteries(Lambda1A) 26.Lacunarity(Lacunarity)
5. Diameter ratio λ2 of arteries(Lambda2A) 27.Central Retinal Artery Equivalent(CRAE LEON) [37]
6. Arterial branching angle(ThetaA) 28.Central Retinal Vein Equivalent(CRVE LEON) [37]
7. Adjusted Gamma ratio of arteries (artgamma) [37] 29.Arteriovenous ratio(AVR LEON) [37]
8. Parent’s arterial width(Width parentA) 30.Central Retinal Artery Equivalent(CRAE KNUD) [38]
9. Large child’s arterial width(Width child1A) 31.Central Retinal Vein Equivalent(CRVE KNUD) [38]
10.Small child’s arterial width(Width child2A) 32.Arteriovenous ratio Knudtson(AVR KNUD) [38]
11.Average junction’s arterial widths(Width allA) 33.Average tortuosity [39] (mean phi)
12.Arterial Angle-to-Branching coefficient 34.Median tortuosity(median phi)
ratio(Angle.BC A) [38] 35.Third quartile tortuosity(75th phi)
13.Alpha value of veins (AlphaV) 36.Standard deviation of tortuosity(sd phi)
14.Branching coefficient of veins (BetaV) 37.Average tortuosity [40](mean tau)
15.Bifurcation index of veins (LambdaV) 38.Median tortuosity(median tau)
16.Diameter ratio λ1 of veins(Lambda1V) 39.Third quartile of tortuosity(75th tau)
17.Diameter ratio λ2 of veins(Lambda2V) 40.Standard deviation of tortuosity(sd tau)
18.Branching angle of veins (ThetaV) 41.Average tortuosity[13](mean psi)
19.Adjusted Gamma ratio of veins (veingamma) [37] 42.Median tortuosity(median psi)
20.Parent’s venular width(Width parentV) 43.Third quartile tortuosity(75th psi)
21.Large child’s venular width(Width child1V) 44.Standard deviation tortuosity(sd psi)
22.Small child’s venular width(Width child2V) 45.Combined tortuosity[41](Tort blend)
23.Average junction’s widths of veins(Width allV)
as used in all the experiments of this work, can be seen in Table 2 (as well as the short form of each
feature, for visualisation purposes, as they will appear in the models and figures).
2.2.4.1 Geometric Features
Widths & Angles
The vessel widths and branching angles (1-24, Table 2) were estimated using the fully automated
active contours algorithm as presented in [32], which is a part of the segmentation algorithm. It
provides precise widths and angles measurements with sub-pixel average width errors.
In addition to the above direct measurements, some additional ones have also been proposed in
literature and are adopted in this work [42, 43]. These are the bifurcation index λ, the asymmetry
ratio α, diameter ratios (λ1 and λ2), and the area ratio or branching coefficient β.
Fractal Dimension & Lacunarity
Fractal dimension (FD) and lacunarity (25-26, Table 2) are another two important features that are
included in these studies. The former can give us a measure of complexity of a structure, as long as it
can be considered a fractal, just like the retinal network [44]. The latter is a measure of heterogeneity
of a fractal structure [45].
For the calculation of FD, the well established method of box-counting algorithm (Minkowski -
Bouligand dimension) was used [46, 47], whereas the gliding-box algorithm [45] was used for the
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estimation of lacunarity.
Arteriovenous ratio
AVR, CRVE and CRAE (27-32, Table 2) were estimated using two different methods. The first one
is the widely used method as introduced in [38], and the second one is a more recent and more accurate
approach, proposed in [37]. The area of interest, in which all measurements are taken, includes the
region where the edges of the vessels course through at 0.5 to 1.0 disc diameters from the OD margin.
The vessels are labelled as artery or vein and measured using a semi-automatic tool described in [33].
Tortuosity
Tortuosity (33-45, Table 2) is another very important investigated feature, considered to be among
the first indicators of the alterations in the retinal vascular network to appear in retinal pathologies
[48]. Tortuosity, in practice, refers to the state or quality of being tortuous, i.e. twisted, having many
turns.
In the present studies, three different methods were utilised, described in details in [13, 40, 39]. The
image-level tortuosity is expressed in terms of mean, median, standard deviation and third quartile
values. In addition, a fourth measure was also used, which is a supervised approach, that provides
a tortuosity index capable to reproduce the clinical experts’ assessments [41]. This index is a linear,
weighted combination of the other three.
2.2.5 Statistical Analysis and Inferences
Each feature under investigation was evaluated using Linear Mixed Models (LMMs). Mixed models
refer to a variety of models that have as main variables both fixed and random effects, which are
combined linearly with an error term to determine a response variable. LMMs capture individual
differences by estimating a different random intercept for each subject [49, 50].
For each feature an LMM is constructed, with the feature as the response variable, the year of
measurement (disease stage) as the fixed effect and the subject identity as the random effect. A second,
so called ”restricted or null model” is also constructed for each feature, with the subject identity as
the sole independent variable. The two models are fitted using maximum likelihood, p-values are
calculated from the likelihood ratio X2 (chi-squared) test of the log-likelihoods of the two models, with
the Akaike Information Criterion (AIC) and the Bayesian Information Criterion (BIC) estimated as
well. The inferences are made by comparing the two models with each other in order to investigate
whether or not the progression of the disease significantly affects the features. The restricted model
was also used to estimate the intra-class correlation (ICC), which describes the proportion of the
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total variance that can be explained by the individual subject identity. The Tukey-test was used to
make post-hoc comparisons and investigate the relationship between the year of measurement and the
statistically significant features. All the relevant assumptions that need to be met, e.g. normality of
the residuals, were tested either by visually inspecting the data (Q-Q plots) or by corresponding tests
(Shapiro-Wilk), prior to running any analysis.
As mentioned, AIC, BIC and p-values are reported. P-values have undergone a great deal of
controversy in whether or not they are a suitable approach of evaluating an effect and communicating
results [51]. In literature, particularly for LMMs, it is suggested to be avoided and instead use other
metrics, such as AIC and BIC. In addition, in LMMs the p-values cannot be directly extracted, because
the estimation of the denominator’s degrees of freedom is not straightforward [52].
In the present study all these metrics are going to be communicated in order to give an overall
performance indication and avoid only to follow a specific evaluation metric. Moreover, for the reasons
elaborated and explained in details in [53], regarding whether the p-values need to be adjusted in
multiple comparisons or not (classicists vs rationalists), and also the fact that hierarchical models
in general might not need such approaches [54], the reported p-values are not adjusted. Besides,
given that all the information needed to adjust the p-values is reported in this work (appendix A in
supplementary materials), one is able to do so, if needed. The significant features will be highlighted,
with the threshold being p-value less than or equal to 0.05.
A metric similar to the R2 of the ordinary linear regression, the Ω20, is also reported. It was
proposed for the LMMs in [55], as a generalised metric for estimating the explained variance or the
effect size. It can be estimated by
Ω20 = 1−
σ2
σ20
(4)
where σ2 is the residual variance of the full model, i.e. the amount of variation in the response Y that
is not explained by the covariates, and σ20 is the residual variance of an intercept-only null model.
2.2.6 Feature Selection and Classification
In order to test the discriminative power of the proposed features, two different approaches were
followed, given their popularity and established performance in a wide range of applications. Both of
these algorithms are selecting a subset of features, based on a fine tuning of the penalty parameters,
prior to the classification process.
First, a regularised random forests classifier (RRF) was used, which is an adjusted for the feature
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selection process random forests classifier, as proposed in [56]. In short, the RRF can select a compact
feature subset, by including an additional penalty coefficient, creating a regularised information gain,
GainR(Xi, u) =
{
λ ·Gain(Xi, u) i 6∈ F
Gain(Xi, u) i ∈ F
(5)
in which u refers to the node and F is the set of indices of features used for splitting in the previous
nodes. The parameter λ ∈(0,1] is the penalty coefficient.
Second, an elastic-net logistic regression was also used, which includes a feature selection step,
based on the least absolute shrinkage and selection operator (Lasso) and ridge regression, creating a
hybrid penalty (trade-off) for the coefficients of the features (L1- and L2- norms) [57].
In addition to the above two methods that will be used both as classifiers and feature selection
processes, a third feature selection process was also utilised. Because the most challenging and im-
portant input for a classification system are the features with the highest discriminative potential, a
third feature selection-only method is used, the all-relevant feature selection algorithm (boruta) [58].
In brief, it works by creating random features (shadowed attributes), which are then compared with
the real features, based on a Z-score. Given that it is a wrapper around random forests, it can provide
a numerical ranking of the features as an importance measure. Then the maximum score among the
shadowed attributed (MSA) is found (in the corresponding figures 7 and 9, this is referred as ”shad-
owmax”), which is compared with the corresponding scores of the other attributes. The attributes
that are found to score statistically significantly higher than the MSA ones are marked as important
(selected features).
2.2.6.1 Validation and Metrics
In order to evaluate the performance and validate the classification models, a number of approaches
were adopted. The evaluation process was conducted by using a 1000 repeated 10-fold cross validation
[59] and a 0.632+ bootstrap [60]. The different models were compared according to their performance
in terms of the average area under the receiver operating characteristic curve (AUROC or AUC), but
additionally, other metrics are also utilised and/or reported, such as kappa and out of bag error (not for
the model comparison, but as a complementary to AUC metric; only for the random forests). Kappa
is preferred to the conventional accuracy, because the latter can be a misleading metric of performance
if used alone, especially when comparing the performance of different classifiers [61]. That is because
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Table 3: Summary of the classifiers, feature selection process and main evaluation metrics
Techniques Overview Process
Logistic regression Linear classifier Classification
Random forests Non-linear classifier Classification
Elastic-net Regularisation & mixing parameters for LASSO and Ridge
regression
Feature Selection
Regularised random
forests
Regularised information gain using penalty parameter Feature selection
AUC Represents a probability, the closer to 1 the better Evaluation metric
ROC Graphical plot for the performance of the classifiers Evaluation metric
kappa Adjusted accuracy based on the balance of the classes Evaluation metric
OOB Prediction error using bootstrap aggregating Evaluation metric
a 75% of accuracy in a balanced design (50-50) is not the same as a 75% of accuracy in an imbalanced
design, where the largest class represents the 70% of the whole sample, for instance. Therefore, there
is another metric, known as kappa, which compares the observed accuracy with the expected accuracy,
yielding a metric that can be used for evaluating both the performance of a single classifier and also
across classifiers [62]. Table 3 recaps the approaches and the evaluation metrics that are going to be
reported.
2.2.6.2 Classification and Training Process
The classification process was conducted for the following four combinations:
1. Comparison of images (averaged) obtained during three years before DR onset vs. an image at
DR onset in the same subjects (DR progressors)
2. Comparison of images (averaged) obtained during four years in subjects who did not developed
DR (non-progressors) vs. image at DR onset in DR progressors
3. Comparison of images (averaged) obtained during four years in subjects who did not developed
DR (non-progressors) vs. images (averaged) obtained during three years before DR onset
4. Comparison of images (averaged) obtained during four years in subjects who did not developed
DR (non-progressors) vs. images (averaged) obtained during three years before DR onset vs. an
image at DR onset (DR progressors) - One versus All method
Combination 1 includes the average of the three year period before the onset of DR, which offers a
more realistic and representative sample of the diabetes-NoDR condition versus DR. Combination
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2 is similar to combination 1, but during this time, the group includes a non-progressors cohort
of subjects with diabetes, for which the last four available consecutive years of diabetes-NoDR are
combined and averaged, in order to form this group that will be tested against the DR one. In
practice, combination 1 includes data from subjects that is known that they are progressors (features
are averaged across the three year period, namely three, two and one year pre-DR), whereas the non-
progressors group includes subjects with diabetes that have not progressed to DR (i.e. they are at
least in earlier stage than the progressors group). Combination 3 investigates whether two groups
of subjects with diabetes that at first sight belong to the same group but in reality they come from
predefined periods, can be correctly identified. In a prospective study this information is not available
and therefore subjects from both categories are mixed up together in the sample. In our case, the
images have been collected in a retrospective way, so it is known a priori that the subjects in the first
group have not progressed to DR yet. Therefore, the purpose here, is to investigate whether two such
different cohorts are being (have been) affected by diabetes the same or to a different level that actually
defines the progression to DR, and can be considered as such. Finally, combination 4, in contrast
to combinations 1 and 2, provides an overview of whether the three main groups, i.e. subjects with
diabetes but No DR (non-progressors - control group), subjects with diabetes but No DR (progressors
group), and DR subjects, can be efficiently differentiated among each other in a joint system. As it
will be stressed further later, if this combination yields a good performance, it can possibly introduce
an alternative way of studying the progression in a clinical environment, since the first two categories,
i.e. subjects with diabetes but No DR (non-progressors - control group) and subjects with diabetes
but No DR (progressors group), denote the progression of the disease.
As aforementioned, the primary objective of this work is to evaluate the discriminative power of
the entire feature set, as an additional, complementary to the statistical analysis step. The secondary
objective is to find the optimum model for each of the above combinations, in order to assess the
potential of these classifiers to having a possible clinical interest. All the features were normalised
before any of the processes is executed. All of the combinations contain balanced classes. An exemption
is the one vs all process, where although the three classes are still balanced, two classes are merged
each time, creating a new one, and therefore performing the classification versus the third class. The
relevant lists of features are provided in Tables 2 and 4. In comparison to the features in Table 2, which
were used for the statistical analysis, for the classification the majority of them is the same, except
for some differences that exist, hence Table 4. The differences refer to the widths and angles of the
20
vessels, which are summarised based on their descriptive statistics, in order to have equal observations
for each feature in the classification, and also one observation per image.
Table 4: Additional features for the classification
Features (Short form)
1.Arterial average branching coefficient(BC Mean Art) 2.Standard deviation of arterial widths (arterySD)
3.Average Branching coefficient of veins (VeinBc) 4.Standard deviation of venular widths (Vein SD)
5.Average arterial widths (MeanArt) 6.Average venular widths (MeanVein)
7.Median arterial widths (MedArt) 8.Median venular widths (MedVein)
9.Standard deviation of arterial angles (ArtAngleSD) 10.Standard deviation of venular angles (VeinAnglSD)
11.Average arterial angles (MeanAngArt) 12.Average venular angles (MeanAngVein)
13.Median arterial angles (MedAngArt) 14.Median venular angles (MedAngVein)
The feature selection process includes various techniques (Section 2.2.6) and steps that are
described below. For the combinations 1-3 the steps are exactly the same, but for combination 4
the process is slightly different. Everything was fulfilled using Rstudio and a number of packages
[25, 63, 64, 57, 56, 65].
As was previously described, each of the feature selection algorithms follows a specific process for
producing a feature subset. Given the randomness behind all the processes involved, the feature subsets
slightly change every time the algorithms are executed. Initially, the data are randomly partitioned
into 10 balanced folds. Leaving one fold aside, the feature selection process is executed 10 times in
total, ending up with 30 different models (10 from each selection process). Each of these models
inevitably includes a slightly different feature subset. In order to arrive at this point and find the
optimum subset, the whole feature set is penalised by the algorithms. Given the complexity of the
feature selection processes, in order to find the optimum regularisation parameters that give the final
subset for each fold, the 0.632+ bootstrap process is executed with 10000 iterations.
Regarding the elastic-net, the parameters of α and λ were bootstrapped within the range of 0 and
1, with a step of 0.01. Similarly, the regularised random forests process was bootstrapped for the
parameters mtry, i.e. the square root of the number of predictors sampled for splitting at each node
rounded down (4 and 5; 6 and onwards gave much inferior results), the penalty λ and the importance
coefficient κ within the range of 0 and 1, with a step of 0.01. At the end of this process the optimum
parameters that give the best classification result (based on AUC) are estimated, which in turn give
the final feature subset for the respective fold. In regards to boruta, for each fold, the maximum
number of importance source runs was set to 10000 and the confidence level of p-value to 0.01.
The validation process starts after having created the 30 models in total from the elastic-net,
the regularised random forests, and boruta, for each combination, apart from combination four. At
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this stage, the final step is to find out, for each combination, which model performs best. For this a
1000 repeated 10-fold cross validation is employed, which gives an average AUC with bootstrapped
confidence intervals and a ROC curve with box plots in different points on the curve (60 classification
models for each combination 1-3, 30 for logistic regression and 30 for random forests). The best five
models of each combination are presented in the results section.
In regards to combination 4, the aim is to figure out whether a classification system - for diagnos-
ing the disease and the progression - that combines the three main scenarios that are of our interest,
is plausible. These scenarios refer to a) the non-progressors’s group, b) the progressors’ group (years
of diabetes-NoDR) and c) the group of subjects with DR. This combination is important, because the
progressors’ group represents the pre-DR situation (we know from our retrospective data the exact
periods) which we would ideally like to know, but in real-world situations we actually do not. Given
that DR is just round the corner, possible treatment interventions to slow down the proliferation might
be feasible. Therefore, such a diagnostic classification system, could be used to identify not only the
transition from the early stage of diabetes-NoDR to pre-DR (or alternatively progressors’ state), but
also to DR.
The one versus all method [66] reduces the problem from multi-class to multiple binary classification
problems, and was preferred due to its reduced complexity and the few available observations that are
not enough for building a meaningful multi-class classifier. The process starts by training a single
classifier per class, with the samples of this class as positive and the rest as negative. To achieve this,
for each combination of classifiers (in this case three), the probabilities must be returned instead of the
predicted class labels. The final prediction is then performed by executing these binary classifiers and
finally choosing the prediction instance with the highest confidence score (probability). Similar to the
other combinations, the evaluation of this ensemble of individual models is fulfilled by a 1000 repeated
10 fold cross-validation, getting one ROC curve for each of the three cases. Three feature subsets were
used to test this ensemble, which are the best feature subsets of the combinations 1, 2 and 3.
3. Results and Discussion
The results that follow shed light on some not previously investigated situations, such as the
progression from diabetes-noDR to DR within a progressors group across a period of time, and the
simultaneous evaluation of a vast collection of geometric features for their discriminative potential.
Following the methodology and approaches that were described in the previous sections, the results
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of each of the six categories of Table 1, as well as those of the combinations of the classifications, are
included in this section and in the supplementary materials.
3.1 Statistical Analysis
All the tables that are quoted below can be found in appendix A of the supplementary materials.
3.1.1 Four Year Matched Study of the Progressors
This group represents the main study of this work, which all the other categories are compared
with. The main hypothesis suggests that the alterations in the retinal vascular geometry during the
last stages of the eye with diabetes-NoDR are distinct; but given the diversity of the retina, a proper
design and analysis are needed, in order to make robust and solid inferences. In this study, the same
subjects and segments are used across the four year period. Therefore the whole study is absolutely
balanced. The purpose is to show a) how different the results can be depending on the design of an
experiment that aims to study the effects of the disease in the retinal vasculature and b) make the
statistical inferences about the progression to DR.
Table A.1 shows the results of the main features, followed by Tables A.2 and A.3, which include
the results of the tortuosity metrics and the post-hoc analysis, respectively.
3.1.2 Four Year Non-Matched Study of the Progressors
This part includes the same data as study 1, but the segments are not registered, so all the
measurements in the main features are used without any selection. The purpose is to find out whether
any differences exist in the results in comparison with the similar study 1, to justify or not the use
of registered segments. Tables A.4 and A.5 show the results of the main features and the post-hoc
analysis, accordingly.
Comparing Tables A.1 and A.4, it is apparent as to why not matching the segments can lead to
controversial results. A series of important features that define the vascular changes, such as arterial
and venular widths, were missed in the non-matched (non-registered bifurcations) design. The same
exact segments, compared over a period of time, can provide more accurate representation of the
underlying changes, regardless of the direction of the effect. A non significant result can be turned
into a significant one with the presence of a few outliers in the sample.
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3.1.3 Four Year Matched Study of the Non-Progressors
This study investigates a group of non-progressors, i.e. subjects with diabetes-NoDR that at the
moment of the data collection had not progressed to DR. They are followed over a consecutive four
year period of time, and the aim is to establish, whether in this period, any significant alterations due
to diabetes occur. Table A.6 shows the results of the main features, followed by Tables A.7 and A.8,
which include the results of the tortuosity metrics and the post-hoc analysis, respectively.
3.1.4 Four Year Non-Matched Study of the Non-Progressors
Similar to study 2, this particular study is the non-matched (non-registered bifurcations) study of
study 3, using the same data but without any matching of the segments whatsoever. Accordingly,
the purpose is to investigate whether any of the differences in study 3 are also observed here, and
vice versa. However, no significant results were found, suggesting that, similarly to study 2, using the
same bifurcations and comparing them over a period of time, vascular alterations can be identified
that could have been missed otherwise (Table A.9).
3.1.5 Progressors Versus Non-Progressors Versus DR
This particular study is very important, because it averages all the years within the progressors
and non-progressors groups, creating one group for each of them. Since the registered segments are
used in both of them, the final values are the average of the same segments across the relevant period
of time. For instance, in progressors group, the three years of measurements are averaged segment-
wise. Finally, in the two groups that are created, a third one, also independent group, is included,
which represents a DR group. Therefore, the analysis is run including three independent groups. The
results of this novel experiment will show us two things. First, whether either of the progressors or
non-progressors groups statistically differ compared to the DR group, and second whether they also
differ between each other. Given that when selecting a cohort with current data it is impossible to
have any information about the future progression, it is likely that many of the selected subjects will
soon progress to DR, i.e. belonging to a progressors group (late stage of diabetes-NoDR). Therefore,
with this study the aim is to investigate, whether a random group of subjects with diabetes but no
DR (non-progressors) differs from a carefully selected progressors group, and therefore intonate the
importance of more carefully selecting the cohorts.
Table A.10 shows the results of the main features, followed by Tables A.11 and A.12, which include
the results of the tortuosity measurements and the post-hoc analysis, accordingly. It comes as no
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surprise that the vascular geometry, both in bifurcation- and image- level, shows differences across
this three group study. It also confirms the initial hypothesis, that the functional impairment and the
vascular adjustments do not only occur when approaching DR, but also within the period of diabetes-
NoDR. It is clear that the changes start much earlier, coming up with some strong and solid indications
that diabetes starts affecting the retinal vessels quite some time before the first lesions appear.
3.1.6 Progressors Four Year Study - Independent Groups
This section is focusing on presenting the results in a similar way to study 1, with just a difference
on the design. The subjects in each group are not the same across all groups. Nonetheless, it is
known that they are coming from the same cohort as in study 1, so they can be compared directly
with each other and make inferences about whether the results are affected, when the subjects are
different. Due to the limited amount of data, the analysis is restricted to the main features. In case
the matching of the segments (i.e. the proposed and suggested way of analysis - study 1) does not
make any difference, then we should be able to observe the same or quite similar results with this type
of design. However, as can be seen in Table A.13, this is not the case, as no statistically significant
results were observed. However, this study shows something that should be stressed further. It is
easy to conclude and make decisions based on misleading results. The same features, with the same
dataset, but slightly differently analysed, change the whole interpretation and direction of the results.
Needless to mention that the retina can drive us to more easily committing these errors, bringing again
to the surface the importance of carefully selecting representative amount of large and small vessels,
if matching the same segments is not an option.
In addition, as can be seen in study 5, these results indicate something extremely important. Two
groups, that both include subjects with diabetes-NoDR and representative amount of measurements,
are statistically significantly different across many features, such as CRVE, CRAE, venular and arterial
widths. This suggests something that has to be taken into account in future studies. The selection
of a cohort that is affected by diabetes has to have stricter requirements, since the alterations in the
retinal vasculature are shown to change during the progression of diabetes, in particular near the onset
of DR.
The ICC values reported in the tables in appendix A show whether the random effect is actually
present in our data, justifying the use of LMMs. Moreover, the Ω2 can give us an additional magnitude
of the explained variance and the effect of the random covariate and the additional grouping. Most of
the significant features in the above categories are observed to have fair values of Ω2.
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To sum up, the statistical analyses of this novel study provide some very important findings. Two
different cohorts (analysis of study 5) can give totally different results, which can lead to contradicting
findings. This enhances the importance of studying the same subjects, and as far as possible, the
same exact segments/junctions over a period of time. Planning an experiment, and recruiting subjects
with diabetes, one cannot know at the moment of the recruitment whether some of these subjects
will progress to DR very soon after. This suggests that the variability within the cohort might be
high enough to be possible to identify subtle vascular changes, when compared to a DR group. This
difference could also suggest one additional thing. The cohort of subjects with diabetes-NoDR (pro-
gressors group) that is about to progress to DR in the near future, presents some noticeable differences,
compared to another non-progressors group, which actually supports the hypothesis that the retinal
vasculature is affected and adapts to the underlying functional alterations that occur right before the
onset of DR. Examples of that can be seen in Tables A.10 and A.11, where many of these features, such
as CRAE, arterial widths and tortuosity, differ significantly between the two cohorts. The findings can
partly be explained by the fact that microaneurysms are formed due to the loss of pericytes, which
apparently precedes the appearance of lesions, whereas vascular occlusion is a consequence of base-
ment membrane thickening and endothelial cell proliferation [67]. These processes, which are initially
subtle, affect the retinal haemodynamics. In the normal retina, blood flow remains constant by the
autoregulated vascular responses over a range of systemic blood pressures and intra-ocular pressures
[68]. Local factors, which target smooth muscle cells in arterioles and capillary pericytes in subjects
with diabetes are controlling the vessels [69]. In the progressors group, prior to the onset of DR,
the significantly altered features, e.g. CRVE, CRAE, fractal dimension, venular and arterial widths,
are following a mixed trend in terms of increase/decrease of mean values. On the other hand, the
generalised tortuosity is increased, suggesting that the progression from diabetes to DR is linked to
more tortuous vessels.
3.2 Classification Models
Following the statistical evaluation of the features, which gives us a specific type of information,
this section aims to utilise these features in practice and also investigate whether a subset of them can
be useful in discriminating between groups of different cohorts. For each combinations 1-3 the results
of the feature selection process and the classification models are presented. For each combination, the
best five models and feature subsets are presented.
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3.2.1 Combination 1
This combination includes two classes; one is the DR group and the other is the average of the
entire three year period pre-DR. This combination attempts to evaluate the changes that have occurred
to the retinal vasculature between the last stages of the eye with diabetes-NoDR and the onset of DR.
The best performance in this combination was achieved by the feature subset and classification as
delivered by the regularised random forest’s classifier (Figure 8, mtry=4, λ=0.89), yielding an AUC of
0.878 (Table 5, Figure 9), and positive predictive value (PPV) and negative predictive value (NPV) of
88.34% and 85.26% respectively.
Table 5: Summary of the classification performance for Combination 1
Summary Best model Model 2 Model 3 Model 4 Model 5
Random Forests
AUC (CI95%)
0.878
(0.753-0.954)
0.865
(0.764-0.958)
0.813
(0.654-0.921)
0.647
(0.489-0.777)
0.672
(0.543-0.798)
Logistic Regression
AUC (CI95%)
0.735
(0.534-0.853)
0.675
(0.521-0.765)
0.754
(0.567-0.843)
0.763
(0.574-0.853)
0.724
(0.531-0.834)
Random Forests
kappa
0.572 0.524 0.511 0.245 0.269
Logistic Regression
kappa
0.468 0.343 0.503 0.509 0.462
Random forests
OOB
0.203 0.234 0.245 0.367 0.389
Feature selection
process
RF BO RF EN EN
The features of the best model for combination 1, ordered according to their importance, are the
following:
Best model: Angle.BC Art, VeinBc, mean psi, Artgamma, CRAE Leon, VeinAnglSD, sd phi, veingamma,
X75th phi, median tau.
Model 2: VeinBc, Angle.BC Art, mean psi, Artgamma, CRAE Leon, VeinAnglSD, Fractal.
Model 3: Fractal, Artgamma, CRAE Leon, VeinAnglSD.
Model 4: Fractal, Angle.BC Vein, Angle.BC Art, CRAE Leon.
Model 5: Fractal, Angle.BC Vein, Angle.BC Art, MedAngArt, ArtAngleSD.
The performance suggests that still distinct changes are occurring that could differentiate between
late stage diabetes-NoDR and DR cohorts, relying only on the vascular geometry (an example can be
seen in Figure 10). In addition, the good performance of the classifier implies that it could be used for
classifying a progressors cohort versus a DR one, since the three year period of available information
is adequate to create a representative sample.
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Figure 8: Ranking of the features of the best model for combination 1, as returned from the random forests feature
selection process.
Figure 9: On the left: ROC curve and AUC of the best model with the confidence intervals for combination 1; on
the right similar information is given for the second best model. This plot is the averaged ROC curve over all the
cross-validation runs, including the variation and the spread estimates around the average curve using box plots. The
spread estimates are shown at 11 equally spaced positions along the curve.
3.2.2 Combination 2
In this combination, the purpose is to evaluate how a classifier can possibly perform in a realistic
situation. If a high performance, reliable and clinically-validated classification model is to be proposed
that could differentiate between subjects with diabetes-NoDR and DR, it needs to include independent
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Figure 10: An example boxplot showing the CRAE LEON feature in both classes for combination 1.
information, given that the future instances that will have to be classified will come from independent
subjects. To test this scenario, the classifier was trained by including information from the non-
progressors and DR groups.
The maximum achieved performance was delivered by a feature subset of boruta and the logistic
regression classifier, giving an AUC of 0.968 (Table 6, Figures 11 and 12), PPV of 96.78% and NPV
98.35%.
Table 6: Summary of the classification performance for Combination 2
Summary Best model Model 2 Model 3 Model 4 Model 5
Random Forests
AUC (CI95%)
0.945
(0.817-0.991)
0.961
(0.869-0.992)
0.943
(0.835-0.987)
0.942
(0.844-0.975)
0.931
(0.812-0.972)
Logistic Regression
AUC (CI95%)
0.968
(0.923-0.999)
0.823
(0.656-0.912)
0.786
(0.643-0.889)
0.794
(0.587-0.887)
0.903
(0.789-0.981)
Random Forests
kappa
0.887 0.907 0.875 0.867 0.854
Logistic Regression
kappa
0.891 0.654 0.567 0.587 0.803
Random forests
OOB
0.113 0.124 0.133 0.122 0.127
Feature selection
process
BO BO BO RF EN
The features of the best model for combination 2, ordered according to their importance, are the
following:
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Best model: CRAE KNUD, CRAE LEON, CRVE LEON, arterySD, Artgamma, CRVE KNUD, BC Mean Art,
ArtAngleSD, VeinBc, sd phi, MedAngVein, MedArt, VeinAnglSD, veingamma, MedVein, Angle.BC Art, X75th phi,
Lambda1V, Tort, mean phi
Model 2: CRAE LEON, CRAE KNUD, CRVE KNUD, arterySD, Artgamma, VeinAnglSD, CRVE LEON,
Medart, VeinBc, ArtAnglSD, BC Mean Art.
Model 3: CRAE LEON, CRAE KNUD, CRVE LEON, Artgamma, arterySD, sd phi, BC Mean Art, MedAn-
glVein, ArtAngleSD, Medvein, MedArt, CRVE KNUD, veingamma.
Model 4: CRAE LEON, MedAngVein, arterySD.
Model 5: MedVein, VeinAngSd, CRAE KNUD, CRAE LEON, CRVE KNUD, CRVE LEON, sd phi, Tort.
Figure 11: Feature selection process with boruta for the best model of combination 2; y axis shows the relative importance
of each feature, whereas x axis includes the features. Green coloured features are the finally selected ones, whereas the
red are the rejected ones.
The interesting part of this combination is that these features are different from the ones in com-
bination 1. This suggests that there are different attributes that differentiate the two diverse cohorts
(non-progressors and progressors) from DR, implying that the vascular changes are not the same across
different periods of time as the disease proliferates. This is something that is also supported by the
statistical analysis. Therefore it is worth investing on collecting representative data from both these co-
horts, and also make all the efforts to be considered separately in prospective studies. The remarkable
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Figure 12: On the left: ROC curve and AUC of the best model with the confidence intervals for combination 2; on the
right similar information is given for the second best model.
performance of this classification model, with the tight confidence intervals as well, provides evidence
that such a model could be used for differentiating between subjects with diabetes-NoDR and subjects
with DR.
3.2.3 Combination 3
Similar to the objective of the statistical analysis of study 2, this combination aims to efficiently
classify a group of subjects with diabetes that are non-progressors, and a group that they are about
to progress to DR soon. This combination has high clinical importance, given that being able to
accurately differentiate between these two groups, can give important indications that one is about to
progress to DR in the near future. The random forests classifier gave the best performance of 0.963 in
AUC (Table 7, Figure 14), 98.77% in PPV and 97.15% NPV, using a feature subset that was selected
by the boruta feature selection process (Figure 13).
Table 7: Summary of the classification performance for Combination 3
Summary Best model Model 2 Model 3 Model 4 Model 5
Random Forests
AUC (CI95%)
0.963
(0.898-0.998)
0.957
(0.887-0.991)
0.955
(0.893-0.997)
0.949
(0.896-0.987)
0.937
(0.867-0.977)
Logistic Regression
AUC (CI95%)
0.923
(0.854-0.995)
0.865
(0.667-0.934)
0.902
(0.756-0.983)
0.845
(0.673-0.921)
0.856
(0.667-0.946)
Random Forests
kappa
0.903 0.896 0.856 0.843 0.823
Logistic Regression
kappa
0.834 0.723 0.805 0.709 0.715
Random forests
OOB
0.092 0.098 0.107 0.111 0.126
Feature selection
process
BO RF RF RF RF
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The features of the best model for combination 3, ordered according to their importance, are the
following:
Best model: CRVE LEON, CRAE LEON, ArtAngleSD, CRVE KNUD, arterySD, CRAE KNUD, BC Mean Art,
Artgamma, MedArt, VeinAnglSD, MeanArt, Angle.BC Art, sd phi, MedVein, Angle.BC Vein, MedAngVein.
Model 2: CRVE LEON, CRVE KNUD, CRAE LEON, ArtAngSD, Veingamma, Medvein.
Model 3: CRVE LEON, ArtAngSD, MeanVeinAng, mean tau.
Model 4: CRVE LEON, BC Mean Art, CRAE LEON, ArtAngleSD, VeinAnglSD, MeanArtAng, sd phi.
Model 5: CRAE LEON, artAngSD, CRVE LEON, Angle.BC Art, CRVE KNUD.
Figure 13: Feature selection process with boruta for the best model of combination 3; y axis shows the relative importance
of each feature, whereas x axis includes the features. Green coloured features are the finally selected ones, whereas the
red are the rejected ones. In yellow colour is a tentative feature, which is not significantly important (with respect to a
p-value ≤ 0.05).
Just as has been indicated by the statistical analysis, it comes as no surprise that features such
as CRAE, CRVE, tortuosity, arterial and venular widths and angles yield a very good performance
in detecting the stages of the disease. This suggests that such a classifier could be used in the near
future for identifying the progression of a-not-yet-progressed to DR subject with diabetes. This is an
important observation, which could be paramount for managing to have a clinical system in the future
32
Figure 14: On the left: ROC curve and AUC of the best model with the confidence intervals for combination 3; on the
right similar information is given for the second best model.
that can assist with the assessment of the disease’s progression, prior to the appearance of lesions. It
goes without saying that a clinical exploitation is contingent upon a much larger sample of data than
what was available in these experiments, in order to investigate the possibility of deploying such a
system in a clinical environment.
3.2.4 Combination 4 - Pilot Study
This final combination presents a pilot classification model, in order to investigate whether a system
that can successfully classify the three crucial stages of the early progression could be feasible. Such
a model can have a direct application in identifying the stage of the disease of a subject, and/or the
probability that he/she belongs to a specific stage. Just like in combinations 2 and 3, it is paramount
to be able to detect the stage of the disease, and possibly assist the clinicians in the decision making
process.
As previously mentioned, in this specific comparison, the best feature subsets from the combinations
1, 2, 3 were used to train the random forests classifier. The best result was obtained by the feature
subset of combination 3 (AUC = 0.821). Figure 15 shows the ROC curves of all the combinations,
as well as the individual ROC curves for each binary classifier. The performance is decent enough to
suggest that it is possible to identify these important stages of the disease. It is also promising that
such a performance was achieved with limited observations and only with information of the retinal
geometry. The further evaluation of such a classifier in a clinical study is definitely useful.
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Figure 15: ROC curves for each of the three combinations used in building the one vs all classification models. For
each feature subset, the plot includes three ROC curves that correspond to the three different possible classifications:
progressors versus the rest, non-progressors versus the rest and DR versus the rest. The upper left plot of combination
3 presents the best results, followed by the one on the upper right of combination 1, and finishing with the one down of
combination 2.
3.2.4.1 Feature Ranking
The top 14 features as they appeared in all of the feature selection processes (90 in total), across
all the different combinations, can be seen in Table 8. This table provides us with very important
Table 8: Ranking of the 14 most selected features
Features Appearances in Models (out of 90) Appearances in Bootstrap
ArtAngleSD 39 45.32%
CRAE LEON 36 44.14%
CRVE LEON 35 44.22%
Angle.BC art 32 40.92%
CRVE KNUD 31 38.45%
ArterySD 29 36.88%
CRAE KNUD 27 33.1%
VeinAnglSD 27 32.65%
BC Mean Art 24 30.36%
Artgamma 20 25.79%
Fractal 20 26.56%
Angle.BC Vein 19 25.31%
MedVein 17 21.4%
Sd phi 17 20.99%
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information, showing that the retinal vascular geometry, and mainly the vessel widths, vessel angles
and tortuosity are strong features, with good discriminative potential, across all the combinations that
were investigated. As was observed both in the statistical analysis and the classification models, the
features of Table 8 shall be taken into account when building a detection system.
3.3 Discussion
Undoubtedly, the retinal vascular geometry is shown to be changing during the progression of dia-
betes, which can possibly be attributed to processes that include, among others, the neurodegeneration,
the subclinical inflammation, the oxidative stress and the dysfunction of the endothelial cells that hy-
perglycaemia also causes [7]. In addition, the dysfunction of the endothelial cells affects the production
of nitric oxide in response to shear stress, which can lead to the development of atherosclerosis, i.e.
the hardening and thickening of the arterial wall, thus the observed arterial alterations.
As it was hypothesised, matching the vessel segments and studying them over a period of time,
one can identify changes that might be missed otherwise. All of the above results strongly suggest
that it is very easy to be misled and come up with conclusions that are not representative of what
is being studied. Nonetheless, the experiments showed that the vascular geometry is indeed affected
during the progression of diabetes, which is more or less in line with some of the previous findings
[2, 17, 70]. The vessel widths, FD, venular angle to BC ratio, CRVE and CRAE were found to be
important discriminative features of progression to DR. CRVE and CRAE observations are in line with
the findings of Klein [71] and partly with [14, 72, 73]. These observations are linked possibly to the
endothelial dysfunction, inflammatory changes, and hyperglycemia, all of which are factors involved
in the pathogenesis of DR [74, 75]. As can be seen in Table A.10, not only is there an increase to both
these features (CRVE and CRAE) between the groups of non-progressors and DR, but also the same
occurs between the non-progressors and progressors. This extends the observations of Klein et al. [71],
suggesting that the changes are not necessarily occurring during or around the DR period, but also
few years earlier than the onset of DR, when the retina is adjusting to the upcoming vascular and
functional alterations. Fractal dimension is also an important feature, with significant changes between
the two cohorts (progressors/non-progressors) and DR, which comes in contrast to the findings in [15].
The results of the classification models suggest that detection systems built solely with information
of the retinal geometry can possibly provide reliable systems that could be tested and incorporated in
a real-world clinical application. These features accommodate the purpose of this work, which is the
early detection of the progression from diabetes-NoDR to DR. Therefore, these novel findings have a
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clear clinical interest.
It needs to be kept in mind that the features that appear in the feature selection processes are those
that can provide a better classification performance, as defined by the corresponding techniques. This
means that highly correlated features that have similar performance might not be selected. Nonetheless,
Table 8 is a strong indicator of which features have good discriminative potential that should be
considered when designing diagnostic systems.
Another important observation is that extensive changes between the non-progressors and the
progressors groups exist, such as in the CRVE, CRAE, the venular widths and tortuosity. This is one
of the key findings of this work, suggesting that changes occur early, much before DR, and continue
until the years before the onset of DR, adopting at this stage the characteristics of a progressors’ group
(instead of a non-progressors). Following that, more alterations are under way, until the first lesions
finally appear in the retina. The findings for the CRAE and CRVE are in line with the ones in [71, 73].
In regards to the classification models, the key and rigorous outcome of this novel study is that it
was succinctly shown that a reliable and high performance classifier can indeed be used to differen-
tiate between different stages of the disease’s progression, implemented only with vascular geometric
features.
4. Conclusion and Future Work
A novel machine learning-based framework and a comprehensive study were presented that combine
a number of geometric features from the retinal vasculature, for detecting the progression to DR. It
was explicitly shown that many features have good discriminative potential. Subject to proper clinical
validation, a decision support system is a feasible target that can assist with the diagnosis of the
progression to DR. The performance of the different classification systems, as presented in this work,
clearly support this statement.
As for the future steps, the author acknowledges the importance of collecting additional data that
can attest and corroborate the findings. Working closely with clinical partners, the efforts are placed
on obtaining such data and apply the FRiAReD on a large scale study, including its clinical validation.
Second, we aim to work on fully automating the framework, in particular the artery/vein classification.
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Appendix A. Data Extraction and Statistical Results
The data that were extracted for conducting the above six studies can be found as follows:
Study 1: Out of the 127 subjects and 508 temporal images, 852 venular junctions were successfully
matched for the main features across the four year period, extracting 2556 venular width measurements.
For the arteries, the total amount was 388 junctions, successfully measuring 1164 arterial widths. The
image-level features of tortuosity, fractal dimension and lacunarity were estimated in the whole set of
images. CRVE, CRAE and AVR features were extracted out of 200 nasal images.
Study 2: 904 arterial and 2534 venular junctions (same number for vessel angles) were included in this
non-matched progressors study (2712 and 7602 arterial and venular vessel widths, respectively).
Study 3: The non-progressors’ group contains 27 subjects across a four year period, including 108 tempo-
ral images. 136 arterial junctions were successfully matched, measuring 408 widths in total. Accordingly,
220 venular junctions were also matched, giving a total number of 660 width measurements. Tortuosity,
fractal dimension and lacunarity were estimated in the whole set of images. CRVE, CRAE and AVR were
extracted out of 80 nasal images.
Category 4: 379 arterial and 594 venular junctions were included in the non-matched non-progressors’
study (1137 arterial and 1782 venular widths, respectively).
Category 5: For the arteries, 228 junctions were included, and similarly 471 venular junctions. Tortu-
osity, fractal dimension and lacunarity were estimated from a total 282 temporal images. CRVE, CRAE
and AVR features were extracted out of 100 nasal images.
Category 6: This final study includes only the main features, but without AVR, CRVE and CRAE. The
127 subjects were randomly assigned to one of the four groups, discarding at random three of the subjects,
in order to have equal numbers of subjects in each group. Therefore, each group comprises of 31 subjects,
who contributed with their non-matched measurements for the analysis. The total number of junctions
were 219 for arteries (657 vessel widths) and 456 for veins (1368 vessel widths). Accordingly, for the
fractal dimension and lacunarity a total number of 124 images were used (31 for each of the four groups).
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Appendix A.1 Four Year Matched Study of the Progressors
Table A.1: Analysis of the main features for study 1
Feature
name
AICa BICa (p-(χ2)b ICC Ω2 Group Means(SD)
(Y3, Y2, Y1, DR)
AlphaA 306.5/
308.8
283.9/
292.4
0.039 0.46 0.605 0.77(0.16),0.82(0.15)
0.81(0.12),0.79(0.16)
BetaA 35.4/
36.4
20.5/
21.7
0.15 0.45 0.657 1.25(0.17),1.32(0.15)
1.27(0.16),1.31(0.17)
LambdaA 600.1/
603.5
578.6/
585.9
0.023 0.484 0.622 0.87(0.1),0.90(0.09)
0.901(0.07),0.885(0.095)
Lambda1A 623.5/
624.8
612.8/
611.2
0.28 0.372 0.604 0.914(0.057),0.923(0.052)
0.908(0.057),0.926(0.052)
Lambda2A 595.9/
600.1
575.1/
581.7
0.017 0.554 0.726 0.807(0.062),0.837(0.061)
0.826(0.068),0.827(0.072)
ThetaA 2578/
2575
2603/
2589
0.536 0.487 0.648 154.1(41),153.6(41.2)
154.9(43.1),148.2(38.4)
Adj.GammaA 689.6/
689.2
675.4/
664.3
0.137 0.463 0.685 0.812(0.08),0.825(0.07)
0.846(0.07),0.817(0.08)
Width_parentA 276.3/
280.7
294.9/
301.2
0.015 0.786 0.882 3.93(0.71),3.81(0.69)
3.86(0.73),3.79(0.65)
Width_child1A 208.3/
210.9
226.2/
228.2
0.05 0.81 0.863 3.65(0.61),3.57(0.62)
3.56(0.6),3.57(0.6)
Width_child2A 170.4/
168.2
195.3/
182.4
0.29 0.667 0.763 3.16(0.43),3.19(0.47)
3.197(0.46),3.125(0.43)
Width_allA 144.5/
146.2
157.9/
159.8
0.043 0.645 0.875 3.585(0.528),3.524(0.559)
3.544(0.565),3.493(0.51)
Angle.BC_A 2531/
2529
2556/
2543
0.265 0.754 0.708 127.4(41.7),121.1(40.5)
126.9(38.7),120.2(35.5)
AlphaV 427.4/
436.6
404.7/
409.2
0.001 0.33 0.577 0.68(0.19),0.71(0.19)
0.737(0.21),0.725(0.19)
BetaV 203.5/
206.7
174.8/
185.5
0.026 0.344 0.62 1.11(0.18),1.15(0.19)
1.14(0.19),1.16(0.21)
LambdaV 1123/
1133
1100/
1105
0.002 0.338 0.593 0.815(0.12),0.832(0.12)
0.85(0.13),0.843(0.12)
Lambda1V 1677/
1672
1657/
1640
0.35 0.335 0.574 0.906(0.062),0.914(0.067)
0.902(0.072),0.909(0.065)
Lambda2V 1371/
1381
1349/
1352
<0.000 0.362 0.636 0.733(0.087),0.754(0.082)
0.759(0.081),0.761(0.091)
ThetaV 182.4/
177.8
214.2/
196
0.71 0.353 0.608 137.1(32.9),136.3(28.8)
137.1(34.5),134.7(33)
Adj.GammaV 1929/
1927
1909/
1897
0.06 0.351 0.611 0.763(0.067),0.765(0.071)
0.768(0.071),0.761(0.073)
Width_parentV 1282/
1285
1312/
1316
0.045 0.624 0.812 4.38(0.9),4.29(0.91)
4.33(0.92),4.21(0.89)
Width_child1V 1078/
1080
1117/
1119
0.046 0.62 0.805 4(0.83),3.935(0.75)
3.931(0.792),3.84(0.746)
Width_child2V 734/
734
766/
765
0.125 0.521 0.708 3.198(0.531),3.219(0.513)
3.277(0.574),3.22(0.475)
Width_allV 840.5/
843.6
856.8/
858.9
0.047 0.333 0.823 3.861(0.694),3.815(0.667)
3.848(0.698),3.792(0.653)
Angle.BC_V 6494/
6498
6510/
6515
0.05 0.501 0.611 124.53(38.32),121.61(38.37)
122.96(42.74),119.91(38.15)
Fractal 531.1/
533.6
515.5/
521.3
0.047 0.796 0.844 1.662(0.06),1.648(0.05)
1.647(0.05),1.632(0.06)
Lacunarity 474.3/
469.8
465.3/
451.8
0.688 0.79 0.832 0.16(0.082),0.17(0.073)
0.171(0.059),0.174(0.078)
CRAE_LEON 608.3/
611.8
626.5/
629.3
0.01 0.75 0.818 20.12(3.04),19.37(2.93)
19.52(3.03),19.28(2.75)
CRVE_LEON 736.3/
745.4
753.5/
756.8
0.001 0.745 0.826 28.88(4.77),26.88(4.4)
27.28(5.03),27.04(4.73)
AVR_LEON 294.5/
289.9
285.6/
272.2
0.31 0.445 0.549 0.691(0.081),0.712(0.084)
0.718(0.091),0.723(0.092)
2
CRAE_KNUD 589.7/
595.8
604.5/
607.4
0.007 0.776 0.843 20.10(2.99),19.33(2.86)
19.56(3.07),19.87(2.82)
CRVE_KNUD 744.3/
753.4
761.1/
763.1
0.001 0.737 0.821 29.56(4.93),27.50(4.45)
28.19(5.03),27.14(4.89)
AVR_KNUD 302.1/
301.1
294.1/
283.9
0.1 0.443 0.562 0.688(0.081),0.704(0.082)
0.702(0.094),0.723(0.093)
a: Full versus Restricted (null) model - the lower the better, b: chi-square p-value
Table A.2: Analysis of tortuosity features for study 1
Feature
name
AICa BICa (p-(χ2)b ICC Ω2 Group Means(SD)
(Y3, Y2, Y1, DR)
mean_phi 2494/
2489
2481/
2464
0.665 0.538 0.631 0.222(0.03),0.223(0.024)
0.223(0.026),0.225(0.028)
median_phi 2222/
2218
2209/
2193
0.488 0.551 0.644 0.139(0.032),0.138(0.033)
0.14(0.037),0.143(0.035)
75th_phi 1739/
1734
1726/
1708
0.823 0.491 0.589 0.347(0.052),0.35(0.04)
0.346(0.052),0.35(0.056)
sd_phi 2758/
2754
2746/
2728
0.72 0.339 0.447 0.24(0.019),0.242(0.017)
0.24(0.018),0.241(0.018)
mean_tau 3550/
3546
3537/
3520
0.6544 0.506 0.603 (3.71(0.98),3.76(0.85)
3.72(0.99),3.8(0.93))x10−2
median_tau 4687/
4684
4674/
4658
0.371 0.652 0.728 (11.1(3.6),11(3.1)
10.9(3.7),11.3(3.7))x10−3
75th_tau 3641/
3637
3628/
3611
0.593 0.554 0.645 (35.4(9),35.2(7.8)
35.1(9.2),36(9.4))x10−3
sd_tau 2452/
2455
2422/
2425
0.05 0.295 0.406 (7.99(2.4),8.3(2.3)
8.1(2.5),8.4(2.3))x10−2
mean_psi 3633/
3629
3621/
3603
0.575 0.539 0.632 (4.47(0.92),4.49(0.86)
4.45(0.89),4.55(0.88))x10−2
median_psi 4276/
4272
4263/
4246
0.493 0.708 0.772 (16.9(5.7),16.7(5.2)
16.9(5.8),17.3(5.4))x10−3
75th_psi 3254/
3250
3241/
3224
0.716 0.606 0.687 (51.4(13.6),51.9(12.7)
52.1(13.3),52.6(13.9))x10−3
sd_psi 3104/
3098
3091/
3073
0.389 0.275 0.383 (7.25(1.3),7.25(1.2)
7.2(1.3),7.3(1.3))x10−2
Tort.blend 989/
986
977/
961
0.41 0.576 0.664 1.009(0.114),1.016(0.103)
1.012(0.114),1.024(0.122)
a: Full versus Restricted (null) model - the lower the better, b: chi-square p-value
Table A.3: Post-Hoc analysis for study 1
Significant LMM
features
Significant Linear
Hypotheses
P-values
AlphaA y3-y2 0.045
Lambda y3-y2 0.04
Lambda2A y3-y2 <0.000
Width_allA y3-DR
y2-DR
0.032
0.043
Width_parentA y3-DR
y3-y2
0.032
0.045
Width_child1A y3-DR 0.048
AlphaV y3-DR
y3-y1
0.019
0.001
BetaV y3-DR 0.035
Lambda y3-DR
y3-y1
0.017
0.002
3
Lambda2 y3-DR
y3-y1
y3-y2
0.001
0.003
0.03
Width_allV y3-DR
y2-DR
y3-y1
0.012
0.048
0.029
Width_parentV y3-DR 0.049
Width_child1V y3-DR 0.048
Angle.BC_V y3-DR 0.032
Fractal y3-DR 0.026
sd_tau y3-DR 0.035
CRAE_LEON y3-DR
y1-DR
0.017
0.049
CRVE_LEON y3-DR
y2-DR
y1-DR
0.034
0.05
0.012
CRAE_KNUD y3-DR
y2-DR
y1-DR
0.023
0.026
0.039
CRVE_KNUD y3-DR
y2-DR
y1-DR
0.036
0.021
0.029
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Table A.4: Analysis of the main features for study 2
Feature
name
AICa BICa (p-(χ2)b ICC Ω2 Group Means(SD)
(Y3, Y2, Y1, DR)
AlphaA 505.3/
501.6
486.7/
468.9
0.498 0.388 0.324 0.801(0.136),0.82(0.145)
0.808(0.125),0.807(0.127)
BetaA 192.3/
187.2
226.4/
206.4
0.846 0.567 0.247 1.302(0.193),1.311(0.202)
1.323(0.197),1.303(0.209)
LambdaA 1509/
1505
1490/
1472
0.461 0.391 0.341 0.858(0.103),0.899(0.065)
0.883(0.042),0.881(0.054)
Lambda1A 1867/
1862
1848/
1828
0.71 0.645 0.241 0.922(0.068),0.92(0.071)
0.926(0.062),0.921(0.065)
Lambda2A 1570/
1566
1551/
1532
0.61 0.419 0.319 0.813(0.079),0.822(0.091)
0.822(0.091),0.815(0.093)
ThetaA 1156/
1155
1189/
1175
0.108 0.687 0.369 145.6(45.1),152.4(49.7)
149.5(48.5),153.9(46.1)
Adj.GammaA 2070/
2065
2051/
2031
0.865 0.574 0.246 0.844(0.079),0.841(0.079)
0.85(0.074), 0.828(0.079)
Width_allA 1384/
1383
1417/
1402
0.159 0.236 0.609 3.422(0.619),3.534(0.643)
3.496(0.652),3.486(0.625)
Width_parentA 1948/
1942
1985/
1967
0.474 0.284 0.559 3.727(0.821),3.841(0.839)
3.791(0.848),3.796(0.814)
Width_child1A 1582/
1580
1621/
1617
0.236 0.229 0.628 3.488(0.714),3.583(0.726)
3.561(0.729),3.549(0.729)
Width_child2A 1049/
1052
1072/
1076
0.02 0.234 0.504 3.049(0.475),3.178(0.504)
3.137(0.501),3.112(0.481)
Angle.BC_A 9216/
9213
9250/
9232
0.444 0.77 0.347 116.40(43.81),119.1(47.39)
117.19(45.5),121.42(46.33)
AlphaV 934.2/
932.3
910.8/
891.9
0.198 0.273 0.175 0.713(0.209),0.728(0.198)
0.735(0.205),0.734(0.207)
BetaV 413.2/
412.8
454.1/
436.1
0.136 0.497 0.215 1.201(0.208),1.217(0.257)
1.232(0.212),1.219(0.203)
LambdaV 3421/
3419
3397/
3378
0.188 0.248 0.181 0.834(0.129),0.844(0.121)
0.848(0.125),0.847(0.127)
Lambda1V 5629/
5623
5605/
5583
0.758 0.591 0.15 0.915(0.067),0.916(0.068)
0.919(0.061),0.915(0.063)
4
Lambda2V 3750/
3749
3725/
3709
0.075 0.323 0.223 0.757(0.102),0.768(0.092)
0.773(0.101),0.769(0.104)
ThetaV 2328/
2327
2369/
2351
0.129 0.108 0.104 137.2(39.1),138.6(38.4)
137.1(38.5),133.6(38.6)
Adj.GammaV 5990/
5989
5967/
5948
0.179 0.521 0.21 0.778(0.056),0.783(0.061)
0.787(0.063),0.773(0.059)
Width_allV 4698/
4697
4738/
4722
0.074 0.125 0.421 3.587(0.71),3.636(0.685)
3.671(0.706),3.638(0.692)
Width_parentV 6310/
6306
6351/
6330
0.581 0.149 0.392 4.009(0.956),4.042(0.924)
4.07(0.941), 4.047(0.943)
Width_child1V 5645/
5642
5686/
5665
0.336 0.122 0.375 3.723(0.84),3.759(0.797)
3.794(0.82),3.759(0.836)
Width_child2V 2981/
3003
3022/
3027
<0.000 0.123 0.407 3.031(0.494),3.108(0.475)
3.149(0.521),3.108(0.466)
Angle.BC_V 24684/
24687
24705/
24711
0.045 0.3 0.154 117.49(37.93),117.38(36.67)
115.74(36.81),114.17(35.21)
a: Full versus Restricted (null) model - the lower the better, b: chi-square p-value
Table A.5: Post-Hoc analysis for study 2
Significant LMM
features
Significant Linear
Hypotheses
P-values
Width_child2A y3-y1
y3-y2
0.042
0.033
Width_child2V y3-DR
y3-y1
y3-y2
0.003
<0.000
0.004
Angle.BC_V y3-DR 0.039
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Table A.6: Analysis of the main features for study 3
Feature
name
AICa BICa (p-(χ2)b ICC Ω2 Group Means(SD)
(Y3, Y2, Y1, Y0)
AlphaA 60.7/
61.1
50.7/
43.5
0.092 0.2 0.145 0.740(0.163),0.805(0.171),
0.82(0.161),0.842(0.142)
BetaA 5.99/
4.76
12.81/
4.05
0.189 0.04 0.341 1.259(0.23),1.35(0.234),
1.38(0.24),1.321(0.212)
LambdaA 169.8/
168.1
158.2/
151.2
0.088 0.277 0.457 0.855(0.095),0.872(0.056),
0.891(0.069),0.895(0.044)
Lambda1A 202.6/
197.9
192.5/
180.4
0.138 0.346 0.334 0.846(0.079),0.856(0.082),
0.863(0.081),0.839(0.077)
Lambda2A 193/
190.1
180.1/
175.4
0.231 0.188 0.431 0.806(0.083),0.819(0.083),
0.815(0.061),0.821(0.055)
ThetaA 69.39/
67.55
86.97/
67.55
0.244 0.234 0.4 143.7(34.1),143.9(33.1),
144.9(33.2),158.6(40.6)
Adj.GammaA 236.9/
235.1
226.9/
217.6
0.241 0.05 0.334 0.813(0.055),0.824(0.056),
0.835(0.053),0.819(0.051)
Width_parentA 105.1/
104.4
121.9/
115.1
0.085 0.467 0.589 4.074(0.505),3.85(0.523),
3.838(0.457),3.912(0.402)
Width_child1A 93.58/
92.28
111.1/
102.3
0.195 0.496 0.585 3.834(0.413),3.669(0.454),
3.689(0.474),3.669(0.421)
Width_child2A 89/
83.71
106.6/
93.75
0.871 0.373 0.442 3.277(0.465),3.254(0.382),
3.304(0.371),3.325(0.437)
Width_allA 69.23/
66.48
86.81/
76.52
0.355 0.505 0.58 3.73(0.415),3.593(0.403),
3.611(0.387),3.635(0.364)
5
Angle.BC_A 875.6/
872.5
893.2/
882.5
0.411 0.211 0.26 112.42(34.42),112.34(37.64),
110.94(35.01),123.99(38.99)
AlphaV 96.49/
92.91
83.44/
70.08
0.489 0.464 0.596 0.581(0.206),0.622(0.234),
0.631(0.218),0.613(0.218)
BetaV 43.05/
41.93
29.99/
19.1
0.181 0.251 0.433 1.121(0.112),1.173(0.124),
1.164(0.142),1.147(0.116)
LambdaV 267.6/
263.9
254.6/
241.1
0.523 0.436 0.57 0.751(0.132),0.775(0.145),
0.782(0.137),0.771(0.141)
Lambda1V 435.3/
430.5
422.2/
407.7
0.745 0.206 0.536 0.816(0.057),0.831(0.053),
0.825(0.076),0.822(0.054)
Lambda2V 344.9/
343.8
331.9/
320.9
0.186 0.397 0.419 0.681(0.098),0.715(0.109),
0.718(0.114),0.705(0.109)
ThetaV 9.89/
5.56
32.73/
18.61
0.642 0.499 0.623 133.1(31.9),135.7(31.6),
136.5(31.4),131.4(30.4)
Adj.GammaV 514.6/
513.4
501.5/
490.3
0.211 0.195 0.435 0.758(0.056),0.765(0.043),
0.767(0.056),0.761(0.054)
Width_parentV 394.2/
391.2
417.8/
404.3
0.51 0.58 0.611 4.879(0.765),4.722(0.791),
4.844(0.853),4.818(0.827)
Width_child1V 416.9/
411.6
439.7/
411.6
0.854 0.41 0.542 4.456(0.747),4.379(0.733),
4.467(0.861),4.435(0.818)
Width_child2V 194.4/
191.6
217.2/
204.6
0.36 0.559 0.534 3.284(0.471),3.332(0.505),
3.415(0.499),3.331(0.401)
Width_allV 284.2/
279.8
307.1/
292.8
0.668 0.559 0.598 4.206(0.571),4.144(0.588),
4.242(0.646),4.195(0.587)
Angle.BC_V 1792/
1788
1815/
1801
0.625 0.422 0.551 123.6(36.37),122.1(32.8),
123.8(33.9),121.4(35.3)
Fractal 146.3/
144.1
141.1/
133.4
0.293 0.641 0.732 1.665(0.049),1.651(0.057),
1.64(0.059),1.643(0.055)
Lacunarity 127.5/
126.9
122.1/
116.2
0.139 0.564 0.69 0.149(0.031),0.167(0.078),
0.186(0.075),0.181(0.059)
CRAE_LEON 458.98/
450.49
460.13/
464.79
0.059 0.053 0.165 18.94(3.19),18.74(3.13),
18.18(3.89),18.01(4.63)
CRVE_LEON 488.93/
483.23
497.29/
495.52
0.098 0.067 0.132 25.76(5.11),26.14(3.98),
26.72(5.23),26.08(5.01)
AVR_LEON 18.94/
15.34
20.09/
14.56
0.668 <0.000 0.019 0.735(0.321),0.716(0.234),
0.681(0.236),0.691(0.2)
CRAE_KNUD 409.26/
407.51
421.4/
416.4
0.052 <0.000 0.118 18.46(2.01),18.24(2.82),
18.02(3.28),17.89(4.32)
CRVE_KNUD 542.38/
538.81
553.1/
549.53
0.084 0.045 0.112 25.45(5.01), 26.01(3.78),
26.31(5.11),25.87(4.87)
AVR_KNUD 55.11/
53.16
46.05/
40.82
0.067 0.056 0.093 0.731(0.311),0.701(0.245),
0.684(0.245), 0.691(0.201)
a: Full versus Restricted (null) model - the lower the better, b: chi-square p-value
Table A.7: Analysis of the tortuosity features for study 3
Feature
name
AICa BICa (p-(χ2)b ICC Ω2 Group Means(SD)
(Y3, Y2, Y1, Y0)
mean_phi 432.19/
427.91
424.62/
412.78
0.631 0.327 0.439 0.218(0.021),0.216(0.022),
0.223(0.027),0.218(0.023)
median_phi 376.63/
373.97
369.06/
358.83
0.342 0.383 0.506 0.133(0.029),0.133(0.03),
0.145(0.036),0.138(0.035)
75th_phi 304.87/
300.66
297.3/
285.53
0.615 0.285 0.397 0.33(0.044),0.345(0.052),
0.345(0.052),0.34(0.044)
sd_phi 487.59/
483.77
480.02/
468.64
0.535 0.166 0.268 0.237(0.012),0.236(0.018),
0.24(0.018),0.234(0.019)
mean_tau 617.68/
612.13
610.11/
597
0.929 0.518 0.606 0.035(0.007),0.034(0.01),
0.035(0.01),0.035(0.01)
median_tau 822.32/
821.96
814.4/
807.19
0.095 0.439 0.576 0.011(0.003),0.0097(0.0025),
0.0112(0.0034),0.0109(0.0033)
75th_tau 671.16/
667.92
663.6/
652.79
0.431 0.545 0.643 0.0331(0.0056),0.0317(0.0065),
0.0332(0.0082),0.0340(0.0084)
6
sd_tau 406.01/
400.21
398.44/
385.07
0.978 0.296 0.393 0.081(0.021),0.078(0.031),
0.078(0.034),0.079(0.026)
mean_psi 652.47/
651.47
644.91/
636.34
0.172 0.549 0.658 0.044(0.005),0.041(0.008),
0.044(0.009),0.044(0.008)
median_psi 748.19/
750.84
735.7/
740.6
0.034 0.44 0.592 0.0158(0.0034),0.0152(0.0038),
0.0178(0.0053),0.0168(0.0048)
75th_psi 616.6/
615.69
609.04/
600.56
0.179 0.585 0.687 0.0516(0.008),0.0488(0.0098),
0.0528(0.0127),0.0519(0.0091)
sd_psi 552.11/
548.14
544.54/
533.01
0.566 0.407 0.517 0.0724(0.0086),0.0691(0.0136),
0.0721(0.0145),0.0728(0.0141)
Tort.blend 161.55/
157.43
153.98/
142.4
0.612 0.375 0.486 0.988(0.091),0.974(0.1),
1.007(0.12),0.986(0.112)
a: Full versus Restricted (null) model - the lower the better, b: chi-square p-value
Table A.8: Post-Hoc analysis for study 3
Significant LMM
features
Significant Linear
Hypotheses
P-values
median_psi y2-y1 0.0325
Appendix A.4 Four Year Non-Matched Study of the Non-Progressors
Table A.9: Analysis of the main features for study 4
Feature
name
AICa BICa (p-(χ2)b ICC Ω2 Group Means(SD)
(Y3, Y2, Y1, Y0)
AlphaA 163.4/
160
147.8/
133.44
0.326 0.109 0.152 0.767(0.181),0.763(0.206),
0.804(0.185),0.798(0.181)
BetaA 62.87/
59.81
90.44/
75.56
0.401 0.015 0.01 1.285(0.202),1.345(0.214),
1.312(0.198),1.321(0.178)
LambdaA 556.65/
553.78
541.65/
526.4
0.377 0.11 0.175 0.869(0.106),0.864(0.127),
0.878(0.109),0.875(0.101)
Lambda1A 828.76/
827.5
813.24/
799.87
0.23 0.015 0.069 0.896(0.086),0.866(0.074),
0.845(0.084),0.85(0.071)
Lambda2A 600.9/
596.9
585.2/
569.4
0.576 0.064 0.09 0.819(0.103),0.832(0.121),
0.826(0.109),0.827(0.104)
ThetaA 436.16/
432.63
463.72/
448.38
0.48 0.09 0.133 142.8(40.1),140.26(38.57),
149.4(47.4),149.6(47.6)
Adj.GammaA 909.68/
907.21
893.45/
879.65
0.316 <0.000 0.01 0.823(0.045),0.825(0.056),
0.833(0.052),0.838(0.061)
Width_parentA 765.28/
763.34
793.88/
778.83
0.373 0.17 0.25 3.823(0.677),3.958(0.710),
4.004(0.717),3.96(0.623)
Width_child1A 735.51/
735.27
762.83/
751.25
0.101 0.173 0.322 3.599(0.619),3.814(0.712),
3.766(0.668),3.762(0.659)
Width_child2A 550.21/
546.42
573.98/
565.75
0.121 0.151 0.233 3.100(0.535),3.244(0.527),
3.297(0.463),3.285(0.496)
Width_allA 602.17/
601.77
629.33/
618.22
0.082 0.189 0.302 3.508(0.56),3.672(0.578),
3.689(0.55),3.669(0.53)
Angle.BC_A 288.99/
285.55
316.55/
301.28
0.467 0.046 0.071 115.34(39.33),111.12(35.21),
119.23(44.53),117.87(40.04)
AlphaV 157.69/
154.94
144.53/
128.62
0.355 0.159 0.179 0.647(0.222),0.668(0.223),
0.677(0.221),0.645(0.216)
BetaV 36.65/
31.33
62.92/
44.94
0.877 0.054 0.066 1.141(0.145),1.159(0.122),
1.154(0.156),1.134(0.175)
LambdaV 706.57/
703.82
693.4/
677.5
0.354 0.165 0.185 0.792(0.141),0.805(0.138),
0.811(0.14),0.791(0.139)
Lambda1V 1343/
1337
1330/
1311
0.927 0.045 0.062 0.836(0.058),0.836(0.059),
0.831(0.062),0.833(0.063)
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Lambda2V 847.72/
844.22
834.56/
817.9
0.475 0.146 0.158 0.737(0.122),0.751(0.118),
0.751(0.122),0.734(0.127)
ThetaV 411.26/
409.12
437.58/
422.28
0.277 0.129 0.152 129.9(33.9),133.3(38.2),
134.9(35.1),127.7(32.6)
Adj.GammaV 1474/
1469
1461/
1442
0.875 0.04 0.05 0.754(0.069),0.767(0.056),
0.774(0.034),0.773(0.063)
Width_parentV 1555/
1551
1582/
1565
0.515 0.197 0.201 4.456(0.97),4.436(0.875),
4.541(0.91),4.63(1.001)
Width_child1V 1465/
1461
1491/
1474
0.679 0.2 0.208 4.156(0.901),4.141(0.809),
4.216(0.865),4.299(0.933)
Width_child2V 808.06/
805.76
404.03/
402.88
0.221 0.188 0.216 3.204(0.523),3.262(0.517),
3.332(0.498),3.303(0.474)
Width_allV 1200/
1197
1226/
1210
0.349 0.208 0.215 3.939(0.732),3.946(0.667),
4.031(0.678),4.077(0.731)
Angle.BC_V 286.56/
281.81
312.88/
294.97
0.741 0.093 0.114 115.93(36.15),118.12(36.92),
118.88(36.34),116.4(35.49)
a: Full versus Restricted (null) model - the lower the better, b: chi-square p-value
Appendix A.5 Progressors Versus Non-Progressors Versus DR
Table A.10: Analysis of the main features for study 5
Feature
name
AICa BICa (p-(χ2)b ICC Ω2 Group Means(SD)
(Prog, Non-Prog, DR)
AlphaA 234.19/
230.28
218.91/
208.15
0.352 0.161 0.215 0.75(0.212),0.785(0.203)
0.792(0.184)
BetaA 133.85/
135.7
151.89/
148.98
0.054 0.031 0.735 1.253(0.171),1.317(0.162)
1.27(0.176)
LambdaA 881.51/
879.54
868.23/
857.40
0.362 0.169 0.225 0.836(0.117),0.878(0.101)
0.872(0.109)
Lambda1A 1306/
1304
1292/
1282
0.372 0.072 0.109 0.912(0.057),0.922(0.052)
0.927(0.044)
Lambda2A 950.77/
950.37
480.39/
478.18
0.111 0.112 0.154 0.803(0.116),0.832(0.111)
0.824(0.113)
ThetaA 806.5/
804.62
826.75/
819.78
0.053 0.108 0.151 147.61(50.47),143.73(43.48)
158.77(48.56)
Adj.GammaA 1429/
1427
1414/
1407
0.058 0.031 0.742 0.782(0.068),0.800(0.063)
0.788(0.068)
Width_parentA 1471/
1479
1501/
1504
0.002 0.341 0.957 4.413(1.071),4.062(0.671)
3.937(0.856)
Width_child1A 1357/
1362
1376/
1379
0.008 0.373 0.409 3.932(0.914),3.663(0.648)
3.675(0.795)
Width_child2A 908.11/
915.12
928.39/
930.24
0.004 0.271 0.778 3.461(0.641),3.167(0.453)
3.181(0.51)
Width_allA 1155/
1162
1171/
1174
0.003 0.373 0.402 4.002(0.839),3.564(0.524)
3.597(0.669)
Angle.BC_A 6329/
6328
6350/
6343
0.076 0.112 0.148 122.17(49.54),114.42(39.72)
125.73(44.77)
AlphaV 49.06/
47.76
78.98/
76.54
0.16 0.576 0.703 0.672(0.231),0.635(0.233)
0.699(0.234)
BetaV 95.45/
91.12
207.83/
204.34
0.23 0.558 0.688 1.141(0.163),1.182(0.141)
1.175(0.178)
LambdaV 677/54/
674.34
663.45/
660.34
0.601 0.141 0.099 0.806(0.149),0.797(0.155)
0.822(0.148)
Lambda1V 1525/
1522
1512/
1499
0.867 0.048 0.077 0.908(0.069),0.912(0.066)
0.912(0.074)
Lambda2V 853.44/
850.97
839.82/
828.28
0.465 0.123 0.165 0.724(0.123),0.717(0.109)
0.722(0.125)
ThetaV 577.06/
576.57
599.26/
590.68
0.105 0.098 0.132 135.91(37.66),125.55(32.26)
137.7(39.7)
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Adj.GammaV 1661/
1659
1647/
1636
0.475 0.09 0.123 0.753(0.064),0.753(0.055)
0.762(0.068)
Width_parentV 2031/
2034
2047/
2053
0.03 0.344 0.943 4.83(1.215),4.423(0.896)
4.476(1.154)
Width_child1V 1925/
1928
1941/
1948
0.035 0.276 0.3 4.458(1.099),4.116(0.893)
4.147(1.061)
Width_child2V 1171/
1175
1188/
1194
0.021 0.276 0.778 3.482(0.691),3.173(0.431)
3.294(0.585)
Width_allV 1618/
1622
1636/
1641
0.021 0.346 0.345 4.256(0.925),3.904(0.652)
3.972(0.861)
Angle.BC_V 7845/
7865
7912/
7918
0.001 0.321 0.506 119.56(37.87),121.45(38.56)
117.62(36.08)
Fractal 628.32/
625.48
618.53/
609.16
0.559 0.837 0.759 1.652(0.058),1.65(0.054),
1.637(0.064)
Lacunarity 543.34/
539.6
533.56/
523.29
0.878 0.806 0.717 0.167(0.071),0.171(0.063),
0.176(0.078)
CRAE_LEON 1025/
1036
1042/
1046
<0.000 0.506 0.593 19.57(3.13),16.29(4.08)
19.51(2.75)
CRVE_LEON 1163/
1165
1175/
1177
0.05 0.515 0.607 27.71(4.92),24.78(5.14)
27.69(4.74)
AVR_LEON 182.2/
179.9
172.4/
163.4
0.451 0.077 0.131 0.682(0.098),0.715(0.092),
0.713(0.094)
CRAE_KNUD 955.9/
964.2
972.3/
974.8
0.002 0.595 0.677 19.58(3.03),17.01(3.18)
19.98(2.82)
CRVE_KNUD 1245/
1248
1255/
1257
0.016 0.413 0.511 28.38(5.03),24.61(7.09)
27.99(4.78)
AVR_KNUD 293.4/
291.9
283.5/
275.4
0.291 0.092 0.165 0.698(0.088),0.726(0.159),
0.723(0.093)
a: Full versus Restricted (null) model - the lower the better, b: chi-square p-value
Table A.11: Analysis of the tortuosity features for study 5
Feature
name
AICa BICa (p-(χ2)b ICC Ω2 Group Means(SD)
(Prog, Non-Prog, DR)
mean_phi 925.1/
924.6
915.1/
907.9
0.197 0.434 0.532 0.229(0.029),0.218(0.023),
0.227(0.027)
median_phi 799.7/
797.5
789.1/
780.9
0.406 0.487 0.584 0.147(0.043),0.135(0.032),
0.143(0.037)
75th_phi 650.1/
649.9
640.3/
632.7
0.213 0.395 0.495 0.361(0.056),0.338(0.046),
0.356(0.053)
sd_phi 1062/
1065
1048/
1052
0.035 0.144 0.198 0.246(0.017),0.237(0.016)
0.249(0.018)
mean_tau 1335/
1336
1325/
1319
0.107 0.382 0.503 0.041(0.011),0.036(0.009),
0.037(0.009)
median_tau 1780/
1778
1770/
1762
0.284 0.405 0.512 0.012(0.003),0.011(0.003),
0.012(0.004)
75th_tau 650.2/
649.2
640.2/
632.2
0.063 0.361 0.484 0.037(0.008),0.033(0.007),
0.036(0.009)
sd_tau 916.8/
915.1
906.8/
898.5
0.313 0.305 0.415 0.089(0.026),0.081(0.027),
0.083(0.024)
mean_psi 1364/
1363
1354/
1347
0.202 0.374 0.488 0.047(0.010),0.044(0.008),
0.046(0.009)
median_psi 1586/
1584
1576/
1568
0.297 0.542 0.645 0.018(0.007),0.016(0.005),
0.018(0.005)
75th_psi 1225/
1222
1215/
1205
0.669 0.453 0.549 0.055(0.015),0.051(0.011),
0.053(0.013)
sd_psi 1173/
1170
1163/
1154
0.638 0.226 0.329 0.075(0.015),0.072(0.012),
0.073(0.014)
Tort.blend 333.4/
334.9
322.1/
323.3
0.061 0.379 0.481 1.056(0.113),0.991(0.105),
1.031(0.115)
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a: Full versus Restricted (null) model - the lower the better, b: chi-square p-value
Table A.12: Post-Hoc analysis for study 5
Significant LMM
features
Significant Linear
Hypotheses
P-values
Width_parentA prog-nonprog
prog-DR
0.001
0.014
Width_child1A prog-nonprog
prog-DR
0.011
0.021
Width_child2A prog-nonprog
prog-DR
0.006
0.013
Width_allA prog-nonprog
prog-DR
0.003
0.011
Width_parentV prog-DR 0.042
Width_child1V prog-DR 0.046
Width_child2V prog-DR 0.043
Width_allV prog-DR 0.03
Angle.BC_V prog-nonprog
nonprog-DR
<0.000
<0.000
CRAE_LEON prog-nonprog
nonprog-DR
<0.000
<0.000
CRVE_LEON prog-nonprog 0.04
CRAE_KNUD prog-nonprog
nonprog-DR
<0.002
<0.001
CRVE_KNUD prog-nonprog 0.01
sd_phi prog-nonprog 0.021
Appendix A.6 Progressors Four Year Study - Independent Groups
Table A.13: Analysis of the main features for study 6
Feature
name
AICa BICa (p-(χ2)b ICC Ω2 Group Means(SD)
(Y3, Y2, Y1, DR)
AlphaA 115.86/
113.24
102.97/
90.66
0.336 <0.000 0.417 0.779(0.184),0.831(0.165),
0.791(0.145),0.813(0.156)
BetaA 125.04/
120.06
148.76/
133.62
0.795 0.489 0.804 1.265(0.301),1.25(0.324),
1.33(0.256),1.351(0.231)
LambdaA 101.83/
96.01
88.27/
72.92
0.978 0.789 0.965 0.807(0.103),0.818(0.106),
0.812(0.122),0.805(0.105)
Lambda1A 428.52/
424.15
414.97/
400.43
0.653 0.04 0.586 0.902(0.067),0.902(0.061),
0.922(0.059),0.926(0.061)
Lambda2A 364.38/
360.76
350.82/
337.03
0.497 0.164 0.865 0.815(0.106),0.851(0.095),
0.835(0.081),0.841(0.097)
ThetaA 301.68/
297.93
325.41/
311.49
0.523 0.316 0.431 1.236(0.351),1.247(0.371),
1.176(0.367),1.347(0.387)
Adj.GammaA 22.78/
17.04
46.52/
30.61
0.967 0.326 0.992 0.838(0.093),0.842(0.097),
0.839(0.097),0.829(0.095)
Width_parentA 587.68/
581.75
611.4/
595.31
0.995 0.752 0.835 3.408(1.346),3.255(1.55),
3.507(1.318),3.383(1.139)
Width_child1A 441.67/
436.48
465.4/
450.04
0.847 0.435 0.991 3.506(0.764),3.613(0.724),
3.638(0.77),3.431(0.604)
Width_child2A 318.86/
315.35
342.45/
328.91
0.476 0.446 0.738 3.072(0.516),3.3(0.609),
3.241(0.589),3.08(0.416)
Width_allA 414.74/
409.17
438.46/
422.72
0.934 0.602 0.902 3.329(0.742),3.39(0.812),
3.462(0.792),3.297(0.608)
Angle.BC_A 2284/
2281
2307/
2294
0.432 0.044 0.116 128.64(54.54),129.45(50.65),
122.45(42.54),128.78(48.32)
AlphaV 88.68/
88.56
74.56/
64.93
0.111 0.014 0.659 0.732(0.212),0.713(0.197),
0.686(0.186),0.771(0.179)
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BetaV 42.39/
42.27
66.05/
55.98
0.106 0.05 0.459 1.136(0.136),1.116(0.153),
1.081(0.182),1.166(0.174)
LambdaV 307.79/
307.71
294.11/
284
0.107 0.023 0.662 0.846(0.125),0.835(0.123),
0.821(0.117),0.872(0.105)
Lambda1V 480.63/
476.89
467.03/
453.11
0.519 <0.000 0.479 0.912(0.061),0.91(0.063),
0.892(0.086),0.908(0.075)
Lambda2V 326.45/
327.62
303.12/
304.56
0.067 0.076 0.576 0.794(0.111),0.783(0.117),
0.753(0.116),0.816(0.105)
ThetaV 219.88/
220.56
234.45/
235.65
0.056 0.045 0.218 145.75(43.5),136.4(36.18),
133.68(40.64),125.77(33.95)
Adj.GammaV 507.39/
507.3
493.34/
492.65
0.115 0.051 0.428 0.779(0.065),0.773(0.07),
0.753(0.077),0.783(0.068)
Width_parentV 595.66/
593.48
619.45/
607.07
0.281 0.307 0.345 3.873(0.906),4.155(1.091),
4.306(0.996),3.783(0.718)
Width_child1V 515.45/
513.08
539.24/
526.68
0.304 0.332 0.369 3.63(0.8),3.871(0.924),
3.931(0.831),3.516(0.534)
Width_child2V 339.97/
334.89
363.76/
348.48
0.82 0.293 0.322 3.025(0.644),3.157(0.544),
3.155(0.468),3.034(0.396)
Width_allV 461.69/
458.37
485.47/
471.96
0.443 0.362 0.385 3.509(0.74),3.727(0.81),
3.797(0.706),3.444(0.502)
Angle.BC_V 2190/
2188
2212/
2204
0.056 0.053 0.430 119.33(37.67),116.57(38.96),
122.01(45.67),108.87(35.23)
Fractal 103.45/
99.19
98.51/
89.06
0.656 0.837 0.891 1.676(0.085),1.669(0.031),
1.644(0.077),1.642(0.053)
Lacunarity 110.34/
109.43
85.12/
83.43
0.345 0.745 0.456 0.163(0.131),0.156(0.102),
0.177(0.098),0.164(0.065)
a: Full versus Restricted (null) model - the lower the better, b: chi-square p-value
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